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Abstract 
 
Nowadays, hazardous organic compounds like pharmaceuticals and personal care 
products (PPCPs) are frequently found in water, especially in low concentration, 
down to ppb-ppt scale. After use, these compounds are delivered into the aquatic 
environment. These low concentrated pollutions by pharmaceuticals found in 
drinking, waste and surface water are a new, emerging problem. Therefore, advanced 
oxidation processes (AOPs) have achieved increasing attention for the water 
remediation such as disinfection, hazardous drug and endocrine disruptive compounds 
(EDCs) degradation. Among AOPs, heterogeneous photocatalysis is of special 
interest, because it does not require additional chemicals and allows to recover the 
solid photocatalysts from the treated water. In this work five types of titania and zinc 
oxide based photocatalysts with different particle size, texture and morphology have 
been prepared, characterized and comparatively tested in the photocatalytic 
decomposition of model drugs: tetracycline and ibuprofen. These are in detail: titania 
doped photocatalysts (Zr-TiO2, Fe-TiO2 and N-TiO2), titania nanotubes, new porous 
titania/MIL-101 composites, metal organic framework MIL-125 and two types of 
nanosized ZnO. The present knowledge of the photocatalytic performances at low 
photocatalyst and pollutant concentrations, the influence of the photocatalyst-to-
substrate mass ratio as well as appearing reaction intermediates is very limited. 
Therefore, this work is dedicated to these above mentioned subjects, in order to clarify 
whether heterogeneous photocatalytic degradation of organics is useful for the 
decontamination of hazardous low concentrated pollutions in water. The formation of 
reaction intermediates of tetracycline and ibuprofen during photocatalytic treatment 
has been investigated by electrospay ionization time-of-flight mass spectroscopy 
(ESI-TOF-MS). An improved procedure for the detection of tetracycline in the ppb to 
ppt range by voltammetry has been developed. In the first time, it has been shown, 
that the photocatalysis with titania and zinc oxide photocatalysts is a very effective 
method for the degradation of pharmaceuticals even at very low concentration (ng/L), 
which is one million times lower than, so far considered in the literature. 
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1. Goals and objectives 
 
The main objectives of this work concern: 
 Evaluation of the potential of titania and ZnO based photocatalysts for the 
photocatalytic abatement of low concentrated pharmaceutical solutions 
tetracycline and ibuprofen under reliable conditions, i.e. in the presence of low 
concentrated pollutants and photocatalyst amount.  
 Novel titania based photocatalytic materials (doped titania, titania nanotubes 
and titania/MOF composites) are synthesized, tested and compared with 
commercial titania P25 photocatalyst. 
 Development of an advanced procedure of the electroanalytical (voltammetry) 
method allowing for the determination of very low concentrated tetracycline 
solution down to the low ppb and ppt ranges. 
 
In details this work aims to:  
 Establish and redefine the State-of-the-Art. 
 Study of the photocatalytic performances beyond “the proof of principle”, 
down to the low ppb scale.  
 Compare of novel titania and ZnO based materials with “standard used“ titania 
P25 photocatalyst. 
 Use of the certain photocatalytic conditions as low pollutant and photocatalyst 
concentrations, low catalyst-to-substrate mass ratios and a solar - light 
equivalent irradiation (by spectral range and light intensity in the UV-A range) 
for photocatalysis. 
 Develop the analytical procedure of voltammetry by optimization of the 
experimental parameters like: buffer, pH value of solution, the deposition time 
and potential and different measurement modes. These variation parameters 
allowed to measure the tetracycline concentration at very low ppb - ppt range.  
 Investigate reaction intermediates of pharmaceuticals formed during the 
course of photocatalytic abatement, by using soft electrospray ionization (ESI-
TOF-MS) method. 
 6 
 
 Prepare novel photocatalysts with improved specific surface area, porosity, 
distinguished titania species and morphology i.e. isolated titania rings in MOF, 
amorphous titanate sheets in nanotubes or titania/MOF nanocomposites: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Initial photocatalysts: 
ZnO and TiO2 
 
 
TiO2        New Advanced Materials          ZnO 
 
 
 
TiO2/MOF 
structures, 
nano doped                       titania            nano ZnO 
    TiO2                        nanotubes 
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2. Introduction 
 
Nowadays, water contaminations like pharmaceuticals, hormones and pesticides are 
very serious problem for human health and clean water supply.[1-4] The emerging 
problems occurring in the aquatic environment, concern markedly increase of type, 
amount and concentration of hazardous, pharmaceutical pollutants. Pharmaceuticals 
are extremely dangerous because they are able to perform biological effects on living 
organisms, sometimes in a non - predicable way.[5-9] After use, these compounds are 
delivered into the aquatic environment. Indeed, more than 4000 compounds are used 
as different human and animal drugs.[10] Recent investigations have shown that a 
number of biological compounds are not completely eliminated by wastewater 
treatment and are also not biodegraded in the environment. Many pollutants occur at 
very low concentrations within the lower ppb - ppt scale[11-13] and have been recently 
detected in drinking water resources (Tab. 1). 
 
Table 1. Concentration of pharmaceuticals found in drinking water in European countries.[14] 
Pharmaceuticals Country Application 
Max. conc 
(ng/L) 
Bezafibrate Germany 
Lipid 
regulator 
27 
Bleomycin UK 
Anti-
neoplastic 
13 
Carbamazepine 
Canada Anti-
epileptic 
24 
USA 258 
Diazepam 
UK Psychiatric 
drug 
10 
Italy 23.5 
Diclofenac Germany 
Analgesic 
and 
anti-pyretic 
6 
Gemfibrozil Canada 
Lipid 
regulator 
70 
Ibuprofen Germany 
Analgesic 
and 
anti-pyretic 
3 
Phenazone Germany 
Analgesic 
and 
anti-pyretic 
400 
Propylphenazone Germany 
Analgesic 
and 
anti-pyretic 
120 
 
Moreover, some active compounds possess an extremely high biological potential 
down to the µg/day doses. Therefore, concentrations which are low as 1 ng/L can be 
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very dangerous. These biological active substances have been found in lakes, rivers 
and oceans.[15-17] There are several possible sources and routes for the occurrence of 
pharmaceutical compounds in the aquatic environment and wildlife (Fig. 1).[18-22] 
Many human pharmaceuticals like non - and some prescription drugs are taken up in 
households, while other prescription pharmaceuticals are consumed in healthcare 
facilities such as hospitals and clinics.[23,24] Emerging environmental contaminants 
occurring in the aquatic environment and wildlife,[25-27] mainly come from industrial 
factories,[28,29] households,[30,31] animal[32-35] and fish farms.[36-38] 
 
 
Figure 1. Fate and occurrence of pharmaceuticals in the environment.[39] 
 
 
Therefore, increasing attention is paid to these compounds as a new group of very 
risky, environmental, recalcitrant water pollutants.[40,41] Figure 2 shows that the 
number of papers dealing with the degradation of these toxic pharmaceuticals 
increases. This increase is not as large as could be expected from the reports of many 
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international organizations which raise alarm over pharmaceutical fates in rivers, 
lakes and oceans, nevertheless the problem cannot be neglected.[42,43] The degradation 
of pharmaceuticals, personal care products (PPCPs) as well as endocrine disrupting 
chemicals (EDCs) is now a very actual, important and demanding task. 
 
 
Figure 2. Number of publications concerning photocatalytic degradation of pharmaceuticals over the 
years 2004-2013 (till May), based on the Science Direct database; keywords: “photocatalytic 
degradation, abatement, pharmaceutical, drug, antibiotic, decomposition, photocatalysis, TiO2, ZnO, 
photocatalyst”; this work. 
 
The number of drugs and their concentrations found in wastewaters constantly 
increases each year. The steroids, common drugs (pain killers) and antibiotics 
occurring in the surface waters in Germany are listed in Table 2.[44]  
Their concentrations may finally achieve the high ppb to low ppm range. Among 
them, nonsteroidal anti - inflammatory drugs (NSAIDs) ibuprofen and naproxen are 
common best known prescribe drugs (due to Consumer Reports: Best Buy Drugs[45]) 
and recently call as the emerging water pollutants.[46-48] The surface water 
contaminants are highly problematic, because they are detected in water streams and 
resources used for drinking water production.[49-52]  
For the effective and efficient degradation of toxic pharmaceuticals, the advanced 
oxidation processes (AOPs) are high of interest.[53-56] In addition, the heterogeneous 
photocatalysis might present an interesting option for pharmaceuticals removal from 
water.[57-63] 
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Table 2. Environmental occurrence of the commonly used drugs in Germany.[44] 
Pharmaceuticals Usage 
Environmental occurrence 
Loading 
of drug 
[g/day] 
Maximal 
concentration 
of drug in 
effluents 
[ppb] 
Maximal 
concentration 
of drug in 
surface 
waters [ppb] 
 
Ibuprofen 
analgesic, 
anti-
inflammatory 
200 3.4 0.53 
Diclofenac 
analgesic, 
anti-
inflammatory 
100 2.1 1.2 
Carbamazepine 
Analgesic, 
antiepileptic 
100 6.3 1.1 
Naproxen 
analgesic, 
anti-
inflammatory 
50 0.52 0.39 
Aminophenazone 
(or aminopyrine) 
analgesic, 
anti-
inflammatory 
50 1.0 0.34 
Gemfibrozil 
blood lipid 
and 
cholesterol-
regulator 
medicine 
50 1.5 0.3 
Indomethacin 
analgesic, 
anti-
inflammatory 
10 0.6 0.2 
 
In the water remediation processes also some other oxidative methods such as 
ozonation,[64,65] chlorination[66,67] and oxidation with H2O2
[68-70]
 are commercially 
available. Unfortunately, they often require expensive chemicals (Cl, H2O2, O3), 
soluble homogeneous catalysts and mixed treatments like O3/H2O2,
[71] 
TiO2/UV/H2O2,
[72] Fe2+/UV/H2O2,
[73] TiO2/UV/O3.
[74] Therefore, these methods tend 
to be more sophisticated in water remediation than popular photocatalysis. It is proved 
that among advanced oxidation processes (AOPs), heterogeneous photocatalysis with 
semiconductors allows for successfully cleaning water from hazardous 
pharmaceuticals. The heterogeneous TiO2 photocatalyst is still the most often used in 
water purification systems (Fig. 3). Titania is a non - hazardous and eco - friendly 
compound, which offers the possibility to be recovered and re-used. In principle, it 
can be widely applied in water remediation because of its special high photocatalytic 
activity and oxidation power. TiO2 is also of high benefit due to its availability and 
reasonable low costs. Moreover, as is observed in Figure 3, doping of titania is also 
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taken into account in the photocatalytic decomposition of drug from water.[75-80] 
Various semiconductors like ZnO and mixture of TiO2 and SiO2 are also more often 
applied in the photocatalysis due to its improved photocatalytic and adsorption 
properties.[81,82] The Science Direct database shows that among 164 papers, titania 
seems to be the most attractive material. Contrary to titania, only 8 of papers the zinc 
oxide is used in the photocatalytic degradation of pharmaceuticals and antibiotics. 
However, non - reliable experimental conditions, different from that occurring in the 
aquatic environment, show that the photocatalytic degradation of dangerous drugs at 
high ppm concentrations (between 10 - 100 mg/L) also require high amount of ZnO 
photocatalyst (0.1-2 g/L).[83-90] 
 
Figure 3. Number of publications concerning the photocatalytic degradation of pharmaceuticals with 
different available photocatalysts: 1. TiO2, 2. metal and non-metal doped TiO2, 3. photo-Fenton 
catalyst, 4. ZnO, 5. TiO2-SiO2, 6. mixed metal oxides, 7. Titanate nanofibers, 8. graphene-TiO2 
composites, 9. TiO2/fly-ash cenospheres over years 2004-2013 (till May), based on the Science Direct 
database; keywords: “photocatalytic degradation, ZnO, antibiotic, pharmaceutical, drug, 
decomposition, photocatalysis”; this work. 
 
Some advanced titania type structures presented in Figure 3, like TiO2 nanowires,
[91] 
titanate nanofibers,[92] nanocarbon TiO2,
[93] graphene - TiO2 composites,
[94] beta - 
cyclodextrin/TiO2,
[95] porphyrin/TiO2 composite
[96] and TiO2/fly - ash cenospheres
[97] 
have found application as photocatalysts.  
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2.1. Semiconductor photocatalysis 
 
Photocatalysis 
Photocatalysis is a one of the most promising technologies for elimination of organic 
pollutants by using heterogeneous photocatalyst (semiconductor) activated by photon 
of proper light energy.[98-101] For this purpose mainly commercially available titania 
(TiO2) photocatalyst is used. The photocatalyst absorbs ultraviolet irradiation from 
sunlight or other artificial light source producing pairs of highly reactive electron hole 
(e- - p+) pairs by excitation of valance band (VB) electrons to the conducting band 
(CB).[102,103] Depending on the excitation energy (band gap) of the photocatalysts 
three different ranges of UV radiation can be used: UV-A (400 - 315 nm), UV-B (315 
- 280 nm) or UV-C (280 - 100 nm). The electron-hole pairs are produced in the bulk 
of the semiconductor and migrate to the catalyst surface for photocatalytic use. The 
photocatalytic oxidation of the organic species often proceeds via adsorption of the 
pollutant on the surface of the catalyst, followed by direct subtraction of the 
pollutant’s electrons by positively charged holes (direct photocatalytic oxidation). 
Another possible way is oxidation with hydroxyl radicals (•OH) at or in the vicinity of 
photocatalyst. The hydroxyl radicals are generated from water by oxidation with 
surface holes or via reduction of dissolved oxygen with CB surface electrons. The 
energy difference between the valence and the conduction band is known as the ‘band 
gap’ (Eg). The wavelength of the light necessary for photo - excitation for TiO2 is: 
1240 (Planck's constant, h) / 3.2 eV (band gap energy) = 388 nm.[104] Generally, the 
difference in the absorption of two modification phases of TiO2 are noticed.
[105] The 
reflectance curves located near the UV part point to the absorption band for anatase at 
wavelength of λ = 377 nm and for rutile at wavelength of λ = 397 nm. 
 
Mechanism of photocatalysis 
Figure 4 shows the stages in the photocatalytic decomposition of organic pollutants 
over titania (top) and time scales of these occurring reactions (bottom). The primary 
reactions indicate the critical role of charge carriers (electron - hole pairs) generation 
and trapping. These processes are very fast. Additionally, two competitive processes 
occur. Firstly, there is a competition between the charge - carrier trapping and the 
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recombination. The trapping of holes (h+) occur very fast (nanoseconds), then the 
somewhat slower recombination proceeds. The same situation is observed with 
electrons (e-). After trapping the electron, the recombination also proceeds. These 
processes are very fast (picoseconds). At the same time, recombination of trapped 
carrier competes with interfacial charge transfer. These stages are slower 
(microseconds to milliseconds). Therefore, the enhancement of charge carrier 
separation (h+ and e-) is of high importance for the photocatalytic activity. To delay 
the recombination and accelerate the charge transfer to the surface different attempts 
(like preparation methods) are taken up. It is assumed that the formed surface bound 
hydroxyl radicals (i.e. trapped holes at the photocatalyst surface) oxidized the 
pollutants.[106] 
 
 
Figure 4. Schematic representation of states occurring on the surface of semiconductors; used 
abbreviations: CB: conduction band, VB: valence band, e-: photogenerated electron, h+: photogenerated 
hole, hv: photon of light, Eg: band gap.[107-111] 
 
 
A photocatalytic degradation usually involves highly reactive radicals or intermediate 
species such as hydroxyl radicals (•OH), photogenerated holes (h+), superoxide 
radicals (O2
•-), and hydroperoxyl radicals (HO2
•), which oxidize a large variety of 
organic compounds.[112,113] The hydroxyl radicals are formed on the titania surface by 
the reaction of holes (h+) with adsorbed water, hydroxide, etc. The photogenerated 
electrons (e-) react with oxygen to generate O2
•-. The formation of hydrogen peroxide 
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(H2O2) requires two electrons for reduction of the adsorbed oxygen.
[114] VB holes are 
more needed, because they have higher oxidation power and are direct sources for the 
hydroxyl radical production (Eq. 2). The formation pathway via of CB electrons 
requires three electrons to produced •OH radicals (Eq. 3, 5 and 6).[115] 
 
{TiO2} + hv → {TiO2}
+
 + e
- 
CB    (1) 
H2Oads + h
+ VB → 
•OHads + H
+      (2) 
O2 + e
- 
CB  → O2
•-        (3) 
O2
•- + H+ → HO2
• 
       (4) 
HO2
• + HO2
• → H2O2 + O2      (5) 
H2O2 + e
- 
CB → HO
• + HO-      (6) 
D + h+ VB → D
•+        (7) 
•OH + D (CxHy) → (D-H)n… +  CO2 + H2O   (8) 
e- CB + h
+ VB → {TiO2}     (9) 
 
In summary, an organic compound (D) can be completely degraded to carbon dioxide 
and water (Eq. 8). The equation 1 represents the charge carrier separation, where 
{TiO2}
+ species are equivalent to generated holes (h+ VB). The equation 9 shows the 
final recombination of holes and electrons on the {TiO2}of bulk material. 
It is generally accepted that the •OH are considered to be the major species 
responsible for the photocatalytic degradation of organic pollutants in wastewater.[116-
119] The oxidative ability of •OH is 2.05 times higher than that of Cl2, 1.58 times 
higher than that of H2O2, and 1.35 times higher than that of O3 (Tab. 3).
[120]  
 
Table 3. Oxidation potential (E) of the reactive oxidants.[121,122] 
Oxidant Oxidation potential [V] 
•OH 2.80 
O3 2.07 
H2O2 1.77 
ClO2 1.49 
Cl2 1.35 
O2  1.20 
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The band gaps and the band edge positions of various semiconductors are given in 
Figure 5. Several metal oxides (TiO2, ZnO, ZrO2, WO3, SnO2, SrTiO3) can be used as 
photocatalysts.[123-127] However, according to the thermodynamic requirement, the VB 
and CB of the semiconductors should be located in such a way that: 
The oxidation potential of the hydroxyl radicals 
 
(E (H2O/
•OH) = 2.8 V vs. NHE) 
 
and the reduction potential of superoxide radicals  
 
(E (O2/O2
•−) = - 0.28 V vs. NHE) 
 
should fit the band gap region of semiconductors.  
 
The redox potential of the VB holes must be sufficiently positive to generate hydroxyl 
radicals and that of the CB electrons must be sufficiently negative to generate 
superoxide radicals. TiO2, ZnO, SrTiO3 and ZrO2 photocatalysts exhibit favorable 
band gap positions compared to the other materials. The effective degradation of 
organic compounds is possible when the redox potential of H2O/
•OH must be within 
the band gap of the semiconductors. The Equation 10 presents the oxidation reaction, 
where the reactive VB hole has an oxidizing potential of ca. 2.73 V vs. normal 
hydrogen electrode (NHE) and can oxidize water molecule to hydroxyl radicals. In 
this condition, semiconductor is able to produce more reactive radicals and easy 
decompose the pollutant molecule. 
 
H2O + h
+ VB → 
•OH     (E of 2.73 V)  (10) 
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Figure 5. Energy-level diagram of the conduction (CB) and valence (VB) bands of different 
semiconductors at pH 0 along with selected redox potentials (E). The energy scales are referred to 
vacuum level and the normal hydrogen electrode (NHE).[128,129] 
 
Doping of semiconductors 
The improvement of photocatalytic activity of heterogeneous semiconductors can be 
done by either morphological modifications such as increasing surface area and 
porosity or by chemical modifications as doping or by incorporation of additional 
components into the photocatalysts structure.[130,131] The chemical modification 
includes the doping of semiconductors by metal or non - metal elements. The doping 
is a processes where an ion of the lattice of a pure semiconductor is substituted by 
metal or non - metal ion or is located interstitial. Also impurities can act as dopants 
(e.g. carbon). The main expected advantages of doping are: 
 
 increasing activity in the decomposition of hazardous contaminations, 
 band gap narrowing for efficient use of visible light,  
 band gap shifting (into visible part of light), 
 lower electron - hole recombination, better charge carrier separation.[132-137]  
 
Efficiency of photocatalysis is limited, because only 2 to 5% of the solar spectrum[138] 
(UV fraction of the solar light) can be absorb by commercial TiO2. The improved 
efficiency might be done by charge carrier separation and band gap shifting into 
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visible part of light. It has been demonstrated, that the visible light absorption and 
photocatalytic activity of TiO2 can be effectively improved by modification of the 
chemical structure involves introduction of metals (Cr, Pt, V, Nb, Fe, Ru)[139-142] and 
non - metals (N, C, S, B).[143-146] 
The doping of titania is effective when the positions of conduction and valence bands 
are between a value of 2.8 V (the oxidation potential of the hydroxyl radicals 
(H2O/
•OH)) and - 0.28 V (the reduction potential of superoxide radicals (O2/O2
•−)). 
The difference of both bands (VB and CB) is corresponding to semiconductor which 
possess the bang gap of ca. 2.8 eV. In these conditions the minimum requirements for 
the doping is achieved. The production of highly active holes (h+) and electrons (e-) is 
maintained. The band gap narrowing (down to ca. 2.8 eV) is a necessary condition for 
the excitation of semiconductor by solar light.  
 
 
Figure 6. Schematic representation of the doped titania particles: a) titania without doping, b) nitrogen 
doped titania, c) iron doped titania and d) zirconium doped titania. 
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Asahi et al. demonstrated that the doping of nitrogen into TiO2 render the formation of 
visible light sensitive TiO2 more easier due to the narrowing of the band gap (Fig. 6 
b).[147] Band gap narrowing is explained by forming the new N2p state with O2p states 
in titania doped with nitrogen. The introduction of nitrogen form a new occupied (i.e. 
electron rich) orbital. It is located between the valence band (which are comprised 
primarily of O2p orbitals) and conduction band (which are comprised primarily of Ti3d 
orbitals).[148,149] Their energies are very close, and thus the band gap of N-doped 
titania is narrowed and able to absorb visible light, extending from a sharp cut off at 
about 390 nm to a broad cut off at above 500 nm. Recently, it was proposed that ion 
doped titania increases the photocatalytic activity.[150-152]  
It is clear that iron (III) ion fits easily into the titanium dioxide lattice, due to a ionic 
radius of 0.69 Å, which is nearly equal to the ionic radius of titanium (IV) (0.745 
Å).[153] This increase of photocatalytic activity can be explained by dual role of iron 
doping, the Fe3+ can trap, both the photoinduced CB electrons and VB holes (Fig. 6 c) 
(Eq. 11-14).[154] 
Fe3+ + e− → Fe2+     (11) 
Fe2+ + 0.5 O2(ads) → Fe
3+ + O2−    (12) 
Fe2+ + Ti4+ → Fe3+ + Ti3+     (13) 
Fe3+ + h+ VB→ Fe
4+     (14) 
 
Additionally, iron atoms in the titania can act the recombination centres for electron - 
hole pairs preventing its recombination (Eq. 15 and 16).  
 
Fe3+ + e− → Fe2+      (15) 
Fe2+ + h+ VB → Fe
3+   
 (16) 
 
However, within the literature review, some reports related doping of titania with iron 
are contradictory. Some authors claimed that iron doping decreases the photocatalytic 
activity.[155,156] 
The titania doping with zirconium shows that the spectral range is extended to 433 nm 
giving a new value of bang gap of ca. 2.8 eV (Fig. 6 d). Although, in many reports the 
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mechanisms of doped TiO2 are not well understood
[157] at this point the minimum 
requirements for the doping is maintained and the obtained Zr-doped titania might 
show enhanced photocatalytic activity.  
 
2.2. State-of-the-Art of the degradation of pharmaceuticals 
 
The study of the State-of-the-Art clearly shows that the decomposition of hazardous 
organic compound is realized in such a way: 
Titania is still the most popular photocatalyst used in the photocatalytic 
decomposition of organic pollutants from water. Photocatalytic tests are done with 
very high pollutant and photocatalyst concentrations, by means working at 
photocatalyst excess. Dyes and phenol contaminations are still used as model 
molecules. Less is known about mechanisms of decomposition of pharmaceutical, 
antibiotics and endocrine disruptive compounds. Real and reliable water conditions, 
i.e. low concentrated pharmaceutical pollutants (ppt - ppb range) are not investigated, 
so far.  
 
In order to simulate polluted sewage water conditions (real water matrix), many 
studies are mainly dedicated to the treatment of highly contaminated wastewater with 
dyes and phenols. Instead of real environmental conditions, were hazardous pollutants 
are present in low ppb - ppt range; very high concentration of model contaminations 
in the mg/L to g/L scale are often investigated. Use of commercially available titania 
in the degradation of dyes is still a main task.[158-161] Contrary to, hazardous 
contaminations like pharmaceuticals, pesticides and hormones are rarely considered. 
Among a huge number of papers considering heterogeneous photocatalysis, available 
in the “Science direct” database, only a limited number of them pointed out 
photocatalytic degradation of drugs (i.e. pharmaceuticals and antibiotics) (Fig. 7). It is 
shown that the most attractive drugs used in photocatalysis are carbamazepine, 
diclofenac, paracetamol, sulfamethoxazole, clofibric acid and ibuprofen, while among 
antibiotics: mainly amoxicillin and tetracycline are chosen for photocatalytic tests. 
These drugs differ in the chemical structure, action and chemical properties and were 
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investigated due to their popularity, most frequent intake by humans or animals or by 
chance. 
 
Figure 7. Types and number of pharmaceuticals used in photocatalytic abatement found in the research 
papers over years 2004-2013 (till May), based on the Science Direct database; keywords: 
“photocatalytic degradation, photocatalyst, TiO2, ZnO, doped TiO2, antibiotic, pharmaceutical, drug, 
decomposition, photocatalysis”, this work. 
 
Mboula et al. used 30 mg/L of TiO2 P25 photocatalyst for the decomposition of 
tetracycline (67 ppm) under 700 W medium mercury lamps.[162] That means, for the 
increasing of the photocatalytic efficiency, huge amount of photocatalytic materials as 
well as high power of lamps are used during the course of treatment. For instance, for 
the photocatalytic decomposition of pharmaceuticals tamoxifen and gemfibrozil of 
concentration varied from 2.5 to 48 and 10 ppm, the concentrations of photocatalysts 
were 0.4 g/L[163] and from 0.1 - 1 g/L[164] of course at high photocatalyst excess and 
by using medium pressure mercury lamps (125 W), respectively. Moreover, the 
photocatalytic degradation of pharmaceuticals at very low concentrations (ppt - ppb) 
is nearly unknown. Only some papers highlighted the mixtures of few drugs, which 
simulated real pollutant matrix of sewage water plants (in ppb scale). In these 
experiments µg/L concentrated water mixtures were investigated.[165-168] In summary, 
the fundamental analysis of the State-of-the-Art shows that almost all studies still deal 
with high photocatalyst amounts, ranged between 0.1 and 2 g/L.   
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This work is dedicated to the photocatalytic decomposition of low concentrated 
tetracycline and ibuprofen over novel based titania photocatalysts and ZnO 
nanoparticles under simulated solar light. The photocatalytic performance is studied 
under reliable conditions, by means, at low substrate and photocatalyst concentrations, 
low photocatalyst-to-substrate mass ratios and under low power of lamps (60 W). An 
own improved electroanalytical method is used to determine the very low tetracycline 
concentration in water. Different experimental conditions (photocatalytic activity, 
adsorption, influence of pH value, re - usability) were investigated in details. 
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3. Results and discussion 
 
3.1. Photocatalytic abatement of ibuprofen and tetracycline 
over titania 25 photocatalyst 
 
The photocatalytic properties of common available titania 25 photocatalyst (Degussa, 
Germany) have been checked during abatement of two model drugs: ibuprofen and 
tetracycline under simulated visible light. In order to redefine and establish the State-
of-the-Art, the influence of the important factors like: photocatalytic activity, pH of 
solution, re-use properties of photocatalyst and formation of reaction by - products 
have been investigated. In order to achieve more reliable results (data) only 
reasonable conditions of photocatalytic treatment have been applied. The low 
photocatalyst and pollutant concentrations, low photocatalyst-to-substrate mass ratios 
(abbreviated: cat-to-sub ratios) of 1 to 4, as well as, low power of solarium lamp (60 
W) supplying ca. 20 % of irradiation (in the part of visible light) have been used. 
These, above given conditions replaced the less reliable ones, widely reported in the 
literature, i.e. very high cat-to-sub ratios (mainly: 20, 50, 100 and etc) and high 
electric power of lamps (mainly > 300 W of pressure Xenon lamps) used as a source 
of light in photocatalysis. 
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Photocatalytic activity 
The photocatalytic performance of the titania photocatalyst has been checked in the 
abatement of ibuprofen and tetracycline from aqueous solution. The cat-to-sub ratios 
were varied by changing the photocatalyst concentrations (from 10 to 40 mg/L) at 
constant IBP and TC (10 ppm) concentration.  
 
 
Figure 8. Photocatalytic abatement of ibuprofen in aqueous solution over titania 25 photocatalyst under 
UV-Vis irradiation; IBP conc.: 10 ppm, cat conc.: 10, 20 and 40 mg/L. 
 
Figure 8 shows the relative abatements of ibuprofen vs. time for different 
photocatalyst concentrations ranging from 10 to 40 mg/L at constant pollutant 
concentration of 10 ppm. In the first 5 min of photocatalytic treatment, over 10 mg/L 
of titania photocatalyst, high relative amounts of IBP have been already decomposed 
(27 %). With prolonged treatment time (after 60 min) the photocatalytic abatement 
proceeds slower. This diminishment of abatement points to a deactivation of the 
photocatalyst during the course of reaction. Ca. 65 to 88 % of IBP is removed after 60 
and 180 min of the treatment, respectively. With increasing photocatalyst 
concentration, slightly higher abatement is observed in the order: 10 mg/L < 20 mg/L 
< 40 mg/L. Even the photocatalyst amount is doubled or multiplied the increase in the 
abatement especially in the first step of treatment (first 60 min) is comparatively low. 
Two reasons can be discussed, a decreased light penetration and photocatalyst 
poisoning by formed reaction intermediates. Excess dosage of the photocatalyst 
decreases the light penetration via “screening” effect of the suspended particles[169] 
and hence reduces the efficiency of photodegradation. The effective reaction rates 
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diminish (Tab. 4). This can be explained by the excessive turbidity of the aqueous 
solution (due to high particle dispersion in the solution) and reduction of photons, 
which are scattered by the TiO2 particles. However, the screening effect was reported 
to occur at higher photocatalyst concentration of > 100 mg/L of titania.[170,171] The 
photocatalyst deactivation is in line with the found fast formation of intermediates at 
the onset of reaction (Fig. 9), which could be connected with the deactivation. 
Formation of oxidized by reactive radicals aromatic intermediates and some 
polymerization of intermediates occurring at the photocatalyst surface might block the 
most active electron - hole species.   
 
 
Figure 9. Formation of the temporary intermediates of ibuprofen in aqueous solution during 
photocatalytic treatment over titania 25 photocatalyst based on UV-Vis absorbance at λmax 262 nm for 
different cat conc.: 10, 20 and 40 mg/L, IBP conc.: 10 ppm.  
 
Figure 9 shows the formation of temporary intermediates of ibuprofen during 
photocatalytic abatement detected by the absorbance at 262 nm in the UV–Vis 
spectra. Interestingly, the appearance and disappearance of temporary reaction 
products is closely related to the abatement curves (Fig. 8). The photocatalytic 
abatement of IBP is very fast at the first onset of reaction leading to rapid formation 
of intermediates. Decreasing abatement beyond 30 min of reaction is accompanied by 
an enhanced decomposition of temporary products. They disappear at the same time 
as IBP is completely abated. This finding additionally confirms that the 262 nm 
absorbance belongs to reaction intermediates. 
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The relative and absolute photocatalytic abatements (A) of ibuprofen and 
corresponding effective first order reaction rates (r) are summarized in Table 4. The 
effective reaction rates of IBP abatement over titania were estimated from 
experimental data. Although the photocatalytic abatements increase with reaction time 
(from 30 to 180 min) the effective reaction rates of photocatalysts decrease. Similar 
tendency is observed with increasing the photocatalyst amount. With higher amount 
of titania, absolutely increase of abatement is observed. E.g. after 180 min of 
treatment the abatements increase in the order 88, 97 and 100 % for 10, 20 and 40 
mg/L of photocatalyst, respectively.  
 
Table 4. Data of the photocatalytic abatement of ibuprofen (10 ppm) in water during 
photocatalytic treatment over titania 25 photocatalyst (cat conc.: 10, 20 and 40 mg/L). 
Relative and absolute abatements (A) and corresponding experimental effective mean first 
order reaction rates (r) calculated after 30, 120 and 180 min of treatment. 
irradiation 
time of IBP 
[min] 
rel. A 
[%] 
abs. A 
[mg/L] 
r 
[min -1] 
rel. A 
[%] 
abs. A 
[mg/L] 
r 
[min -1] 
rel. A 
[%] 
abs. A 
[mg/L] 
r 
[min -1] 
10 mg/L 20 mg/L 40 mg/L 
5 17 1.7 0.0340 27 2.7 0.027 34 3.4 0.0170 
30 48 4.8 0.0160 51 5.1 0.0085 68 6.8 0.0057 
120 76 7.6 0.0063 89 8.9 0.0037 99 9.9 0.0021 
180 88 8.8 0.0048 97 9.7 0.0027 100 10 0.0014 
 
 
Figure 10 shows the specific abatement (mg substrate per mg photocatalyst) of 
ibuprofen over titania vs. the cat-to-sub (IBP) ratios achieved after different times of 
photocatalytic treatment. As expected, observed specific abatement (mg of IBP per 
mg of photocatalyst) increases with longer reaction time, especially at low cat-to-sub 
ratios, ranging from 1 to 0.16, i.e. at low photocatalyst amount.  
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Figure 10. Specific abatement [mg IBP/ mg cat] of ibuprofen in aqueous solution over titania 25 
photocatalyst vs. the cat-to-sub ratios of 1:6≈0,16, 1:4=0,25, 1:2=0,5, 1:1=1 and 1:0.5=2), after 
treatment times of 5, 20, 60 and 120 min, at constant cat conc.: of 10 mg/L. An asterisk (*) 
corresponding to the mostly used in the literature concentration ranges > 100; e.g. cat-to-sub ratio of 
100; for the 10 ppm of pollutants and the 1 g/L of photocatalyst. 
 
Additionally, the photocatalytic abatement of tetracycline over titania has been 
studied at the different photocatalyst concentrations (Fig. 11). Again, the course of 
abatement over titania photocatalyst shows two steps, a fast step of TC abatement at 
the onset of reaction (until 30 min) and then after 60 min a slower ones indicated by 
the lower slope of the abatement curve.  
 
 
Figure 11. Photocatalytic abatement of tetracycline in aqueous solution over titania 25 photocatalyst 
under UV-Vis irradiation; TC conc.: 10 ppm, cat conc.: 10, 20 and 40 mg/L. 
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Compared to the abatement of IBP, the degradation of TC over titania is lower 
(compare Fig. 8). Generally, the courses of abatement of IBP and TC are similar. 
With growing photocatalyst amounts meaning excess of photocatalyst by mass, the 
abatement increases in the order: 10 mg/L < 20 mg/L < 40 mg/L, but again less than 
expected by the high excess of photocatalyst. At the onset of treatment, after 30 min 
of treatment, the obtained abatements of TC are similar for the different photocatalyst 
concentrations This points to a photocatalyst poisoning (blocking) of most active 
sites, at the surface created by electron - hole pairs, e.g. by formed polymeric species. 
This leads likely to a decrease of the effective reaction rates with time (Tab. 5) and 
with increasing photocatalyst amount. 
 
Table 5. Data of the photocatalytic abatement of tetracycline (10 ppm) in water during photocatalytic 
treatment over titania P25 photocatalyst (cat conc.: 10, 20 and 40 mg/L). Relative and absolute 
abatements (A) and corresponding experimental effective mean first order reaction rates (r) calculated 
after 30, 120 and 180 min of treatment. 
irradiation 
time of TC 
[min] 
rel. A 
[%] 
abs. A 
[mg/L] 
r 
[min -1] 
rel. A 
[%] 
abs. A 
[mg/L] 
r 
[min -1] 
rel. A 
[%] 
abs. A 
[mg/L] 
r 
[min -1] 
10 mg/L 20 mg/L 40 mg/L 
5 11 1.1 0.0220 23 2.3 0.0230 22 2.2 0.0110 
30 45 4.5 0.0150 49 4.9 0.0081 54 5.4 0.0045 
120 62 6.2 0.0051 75 7.5 0.0031 87 8.7 0.0018 
180 74 7.4 0.0041 85 8.5 0.0024 96 9.6 0.0013 
 
The determination and investigation of TC intermediates formed during treatment by 
UV - Vis spectroscopy is not possible, due to overlap any possible bands assigned to 
intermediates with TC absorption bands. I.e. no other bands arise during 
photocatalytic treatment. This tend to following the TC intermediates formed during 
the course of abatement only by ESI-TOF-MS measurements.  
In summary, the effective reaction rates for IBP and TC are only slightly higher for 
IBP compared to TC. However, the onset abatement within the first 5 min of 
treatment is substantially higher for IBP with 25 % compared to 10 % for TC for 10 
mg/L of photocatalyst at 10 ppm of substrate. Both factors lead to higher final 
abatement of IBP, compared to TC. 
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Influence of pH solution 
The pH value is an important reaction parameter. It influences the formation of 
reactive oxygen species e.g. ·OH radicals and the improves photocatalyst - substrate 
interactions (adsorption) by changing the surface charge of the photocatalyst and the 
substrate molecule. The influence of the pH value on the abatement of ibuprofen and 
tetracycline over titania (cat-to-sub ratio of 2:1) has been tested under acidic (pH=3), 
neutral (pH=7) and alkaline (pH=9) conditions. 
 
 
Figure 12. Influence of pH value of the reaction solution on the photocatalytic abatement of ibuprofen 
in aqueous solution over titania 25 photocatalyst under UV-Vis irradiation; IBP conc.: 10 ppm, cat 
conc.: 20 mg/L. 
 
Figure 12 shows that the course of ibuprofen abatement over titania at different pH 
solutions is almost similar and does not differ markedly. Rapid abatement of IBP in 
the first stage of reaction (within 60 min) is observed in all cases. Then with 
prolonged treatment time from 60 to 180 min the abatement proceeds distinctly 
slower. The final abatement decreases in the order: neutral > alkaline > acidic and 
finally reaches ca. 97, 91 and 82 %, respectively. Under both, acidic and alkaline 
conditions the abatement is decreased probably by enhanced electrostatic repulsion 
between the substrate and the photocatalyst surface. This finding can be explained in 
the following way. The point of zero surface charge (Pzc) of TiO2 is close to pH of 
6.8.[172]  
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The surface of titania is positively charged in acidic solution (pH < 6.8) while 
negatively charged in alkaline ones (pH > 6.8). The following Equations (17 and 18) 
illustrate this acid - base chemistry of TiO2 surface. 
 
TiOH + H+ → TiOH2
+  (acidic conditions)  (17) 
TiOH + OH- → TiO- + H2O (alkaline conditions) (18) 
 
where: TiOH2
+, TiOH, and TiO- are the positive, neutral, and negative surface 
hydroxyl groups on the TiO2 surface, respectively.
[173,174] Lower pH (acidic 
conditions) will lead to the protonation of titania surface with proton (H+) from acid 
(solution adjusted with HCl) as well as of the carboxyl sodium group (-COONa) of 
ibuprofen. Whereas, at higher pH (solution adjusted with NaOH) the titania surface 
becomes negatively charged due to deprotonation (with hydroxide ions OH-) leading 
to a repulsion of the IBP anions. As a result, adsorption of the substrate at the 
photocatalyst surface is diminished, leading to a decrease of the reaction rates and 
finally decrease of the photocatalytic activity. Therefore, under both, acidic and 
alkaline condition the abatement of ibuprofen is diminished, compared to the neutral 
solution. Additionally, a slightly higher activity of titania under alkaline conditions 
may be attributed to the increased formation of reactive ·OH radicals by 
photocatalytic oxidation of hydroxide ions (OH-) on TiO2 surface.
[175] 
 
In Figure 13 the formation of temporary intermediates of ibuprofen at different pH 
values was again followed by UV-Vis spectroscopy at IBP and photocatalyst 
concentrations of 10 ppm and 20 mg/L, respectively. The formation of by-products is 
attributed by the appearance of the band at 262 nm. During the course of reaction, the 
characteristic IBP absorbance at 222 nm is diminished, whereas the new band at 262 
nm is simultaneously arising. These intermediates appear immediately with 
photocatalytic treatment due to high abatement observed at the very beginning. 
Moreover, highest formation of temporary products at the onset of reaction is 
observed under neutral conditions. 
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Figure 13. UV-Vis spectra of an aqueous ibuprofen solution after photocatalytic treatment over titania 
25 photocatalyst under UV-Vis irradiation: (1) starting IBP solution (10 ppm) and after (2) 5 min, (3) 
30 min, (4) 60 min, (5) 120 min, (6) 180 minutes of photocatalytic treatment. Concentration of 
ibuprofen determined based on the absorbance at 222 nm. Experimental conditions: IBP conc.: 10 ppm, 
cat conc.: 20 mg/L, pH=7. 
 
In addition to, the formation of intermediates is markedly lower under acidic or base 
conditions (Fig. 14). The concentration of intermediates decreases again after 
reaching maximum at 30 min of reaction. The disappearance of temporary reaction 
products is closely related to the achieved abatement in this period of time (Fig. 12). 
 
 
Figure 14. Formation of temporary intermediates of ibuprofen in aqueous solution during 
photocatalytic treatment over titania 25 photocatalyst based on UV-Vis absorbance at λmax 262 nm for 
different pH solutions of 3, 7 and 9; IBP conc.: 10 ppm, cat conc.: 20 mg/L. 
 
Their decrease depends on the pH value of the reaction solution in the given order:  
pH 7 > pH 9 > pH 3. 
intermediates 
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The photocatalytic abatement of tetracycline over titania photocatalyst at different 
pH values of solution has been also investigated. The decrease of the TC absorbances, 
at wavelength by 358 nm in the UV - Vis spectra of photocatalytic treated solutions is 
shown in Figure 15. 
 
 
Figure 15. UV-Vis spectra of an aqueous tetracycline solution after photocatalytic treatment over 
titania 25 photocatalyst under UV-Vis irradiation: (1) starting TC solution (10 ppm) and after (2) 5 
min, (3) 10 min, (4) 30 min, (5) 60 min, (6) 120 and (7) 180 minutes of photocatalytic treatment. 
Concentration of tetracycline determined based on the absorbance at 358 nm. Experimental conditions: 
TC conc.: 10 ppm, cat conc.: 20 mg/L, pH=7. 
 
As it can be seen, in the derived abatement curves, the tetracycline removal is high 
and markedly influenced by the pH value especially under acidic conditions. Figure 
16 shows the photocatalytic abatement of tetracycline at pH of 3, 7 and 9. It is 
observed that the impact of pH value on the abatement of TC is much more 
pronounced at the onset of reaction. Significant increased abatement of tetracycline is 
observed in the first stage of reaction (up to 60 min) and then further followed by a 
slower abatement between 120 and 180 min (low slope of degradation curve). In 
principle, the course of abatement becomes similar at the end of the photocatalytic 
performance.  
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Figure 16. Influence of pH value of the reaction solution on the photocatalytic abatement of 
tetracycline in aqueous solution over titania 25 photocatalyst under UV-Vis irradiation; IBP conc.: 10 
ppm, cat conc.: 20 mg/L. 
 
 
The comparatively low abatement of TC at the very onset of treatment at low pH 
reflects the impact of TC zwitterionic nature of tetracycline (Fig. 17).  
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Figure 17. Acid-base equilibria and ionization (speciation) states of tetracycline (a) pKa=3.3 (ab
+c), (b) 
pKa2=7.5 (a
-b+c), (c) pKa3=9.4 (a
-b+c- or a-bc-).[176] 
 
At this point, at acidic conditions, cations of TC (mostly protonated states (ab+c)) are 
formed which increase the repulsion with positive charged titania surface. The low 
onset abatement results in a different shaped abatement curves. Later, with prolonged 
reaction time, other factors could interfere with abatement and change the nature of 
TC molecule, e.g. the enhanced formation of TC by-products. Finally, the observed 
abatements after 180 min are similar under alkaline (pH=3), neutral (pH=7) and acidic 
(pH=9) conditions, resulting the abatement with ca. 78 and 84 %, respectively. 
Increase activity of titania under alkaline conditions may be again attributed by 
increase amount of reactive ·OH radicals on TiO2 surface (Scheme 1). This finding is 
in agreement with Zhu et al. who showed that the decomposition of tetracycline from 
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the aqueous solution succeed better in alkaline solution than in acidic one. After 
10 min of irradiation over titania (cat conc.: 1g/L and TC conc.: 40 ppm) ca. 70, 75 
and 88 % of TC have been removed at pH 3.0, 7.0, and 9.0, respectively.[177]  
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Scheme 1. Schematic representation of the interactions between titania hydroxylated surface and 
tetracycline molecule at acidic and alkaline solutions.   
 
Formation of ibuprofen and tetracycline intermediates 
The identification of temporary ibuprofen and tetracycline intermediates, formed 
during photocatalytic treatment, has been checked by electrospray ionization mass 
spectroscopy (ESI-TOF-MS). The negative ESI-TOF-MS spectra of the ibuprofen and 
tetracycline exhibit molecular ion peaks [M-H]-, which are sorted according to the 
mass-to-charge peaks (m/z). The [M-H]- peaks of the IBP and TC anions appear at m/z 
205 and 443, respectively (Fig. 18 and 19).  
After 30 min of photocatalytic treatment of ibuprofen, besides the IBP anion peak at 
m/z 205 [M-H]-, peaks at m/z 221, 251, 277, 305, 319 and others appear abundantly. 
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Obviously, these higher molecular mass peaks belong to oxidation by-products of IBP 
and further reaction products of intermediates (Fig. 18). For instance, the m/z 221 and 
251 peaks belong to side - chain oxidation products. Deeply discussion will be given 
below (compare Chapter 3.2). Lower molecular ion [M-H]- peaks arising at m/z 175, 
146, 133, 129 and lower likely belong to deeper oxidized degradation products like 
aromatic ketones, carboxylic acids or phenols. The appearance of these molecular 
peaks is in line with the UV-Vis measurements. The absorbance at 262 nm in the UV-
Vis spectrum related to intermediates reaches maximum intensity after 30 min of 
reaction and finally disappears after 180 min (compare Fig. 9). After 240 min of 
photocatalytic treatment a couple of peaks almost totally disappear (data not shown), 
indicating nearly fully degradation with prolonged treatment time. 
 
 
Figure 18. Negative ESI-TOF-MS spectrum of the aqueous ibuprofen solution after 30 min of 
photocatalytic treatment over titania P25 photocatalyst under UV-VIS irradiation; IBP conc.: 20 ppm, 
cat. conc.: 20 mg/L. 
 
As was earlier mentioned the determination of by-products of tetracycline by UV-Vis 
spectroscopy was not possible.  
 
The negative ESI-TOF-MS spectrum obtained after 240 min of photocatalytic 
treatment shows a couple of tetracycline by-products, which still remain in the 
solution (Fig. 19). 
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Figure 19. Negative ESI-TOF-MS spectrum of the aqueous tetracycline solution after 240 min of 
photocatalytic treatment over titania P25 photocatalyst under UV-VIS irradiation; TC conc.: 20 ppm, 
cat. conc.: 20 mg/L. 
 
Until now, only single studies proposed the possible degradation tetracycline 
pathways, including TC intermediates formation in the presence of additional 
oxidation agents as ozone or hydrogen peroxide.[178-180] Besides the tetracycline 
molecular peak [M-H]- at m/z 443, a lot of new peaks, in the lower m/z range between 
ca. 92 and 200 appear. They belong to degradation products of the tetracycline like 
phenols, ketones, aldehydes or organic acids and impurities.[181] Additionally, new 
peaks arise in the range between m/z 265 and 325. These differences in m/z mass 
peaks strongly imply that signals differ in masses, in following order: 12, 14, 18, and 
16 belonging to some ring opening substituents. The given masses are familiar to 
open ring products of TC (between 265 and 325), especially, from intermediate 
anthraquinone derivates and/or from phenol substituents. The ring opening products 
are further decomposed to organic acids (lower masses, between m/z at 90 and 180) 
like aliphatic acids, alcohols or ethers. The decrease of the TC concentration after 
long time of treatment is accompanied by the further increase of reaction 
intermediates, which can poison the surface of titania photocatalyst.  
As was former discussed, the TC abatement is lower than for IBP over titania 
photocatalyst and was assigned to a partial blocking of the photocatalyst by larger 
amount of TC intermediates found with ESI-TOF-MS measurements.  
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Re-use experiments 
The photocatalyst lifetime (re-use experiments) has been checked in the 
photocatalytic abatements of ibuprofen and tetracycline during 3 cycles (runs) of 
treatment. The cat-to-sub ratio was 1:1 (cat. conc. 10 mg/L and drug conc. 10 ppm). 
Figure 20 shows cycling experiments with ibuprofen over titania. Ca. 87 % of 
ibuprofen has been removed in the first cycle of experiment by applying a low cat-to-
sub ratio of 1.1. Already, in the second cycle, a substantial decrease of the 
photocatalyst activity is observed. The abatement of IBP reaches 74 % after 180 min 
of photocatalytic treatment. Finally, in the 3rd cycle the abatement reached only 48 %.  
 
 
Figure 20. Photocatalytic abatement of ibuprofen in aqueous solution over titania 25 photocatalyst 
under UV-Vis irradiation after 3 runs of treatment; IBP conc.: 10 ppm, cat conc.: 10 mg/L. 
 
Decreasing photocatalyst activity is also reflected in the formation of IBP 
intermediates. The concentration of temporary products immediately increases after 
starting the photocatalytic treatment. Thereafter, concentration of intermediates is 
slightly decreased with treatment time (graph not shown). Diminishing of the activity 
in the cycling experiments is accompanied by accumulation of IBP by-products in the 
treated solution and corresponding poisoning of the photocatalyst surface.  ESI-TOF-
MS data confirm the oligomeric species from reaction intermediates.  
Therefore, it is suggested that growing intermediate formation during cycling 
experiments leads to poisoning of the photocatalyst (reactive surface sites) by formed 
oligomers. This process is accelerated with cycling due to growing formation and 
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presence of temporary intermediates. Reaction by-products are then hardly 
decomposed. 
The re-use experiments have been also carried with tetracycline. As is observed in 
Figure 21, the first run of photocatalytic treatment of TC the photocatalyst shows 
comparatively high activity in the abatement (ca. 74 %). This efficiency in the 1st run 
is ca. 13 % lower than in case of abatement of ibuprofen, where abatement reached 
ca. 87 % (compare Fig. 20). In the 2nd and 3rd run a significant loss of activity is 
observed. This finding reflects poisoning of the titania surface by TC intermediates. 
 
 
Figure 21. Photocatalytic abatement of tetracycline in aqueous solution over titania 25 photocatalyst 
under UV-Vis irradiation after 3 runs of treatment; TC conc.: 10 ppm, cat conc.: 10 mg/L.  
 
Summary 
 Photocatalytic treatment of ibuprofen and tetracycline over commercial titania 
was investigated in detail. Beyond the State-of-the-Art and “the proof of 
principle” (given in most papers) more precise and reliable experimental 
conditions have been showed. 
 Titania photocatalyst is an effective photocatalytic material. Ca. 97 % of IBP 
and 85 % of TC have been effectively abated from solution (cat-to-sub ratio of 
2, 180 min of photocatalytic treatment, simulated sun light of solarium lamps). 
Titania shows very high onset activity.  
 The abatement of IBP is somewhat higher compare to TC. The increase of 
abatement in the onset of reaction (within first 30 min) is similar for both 
pharmaceuticals. At this point the reaction rates (r) are higher and reach of ca. 
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0.016 and 0.015 for IBP and TC, respectively. Further, with prolonged 
treatment time from 30 to 180 the markedly decrease activity is observed. 
However, this decrease in the abatement of IBP is lower (r =0.0033), compare 
to TC (r=0.0024). This finding is in line with fast deactivation of catalyst. 
 Influence of pH solution during abatement of IBP over titania is marginally 
and is not as much influenced than in case of TC abatement. The change of pH 
value has impact on the TC abatement because of changing zwitterionic nature 
of TC molecule, as well. The pH of 7 is optimum for the decomposition of 
IBP. This value is close to real (environmental) water condition. 
 The formation of reaction intermediates is related to the course of abatement. 
At the beginning of treatment lower formation of by-products is observed. At 
the first stage, the formation of TC and IBP intermediates proceeds rapidly 
(consistent with high abatement). With prolonged treatment time both 
pharmaceuticals are transforming to by-products (abatement is lower due to 
the deactivation). Then, finally intermediates are decomposed, what is 
indicated by low intensities of ESI-TOF-MS spectra. 
 
3.2. Photocatalytic abatement of ibuprofen and tetracycline 
over zirconium doped titania (Zr-TiO2) photocatalyst 
 
Zr-doped titania of anatase structure have been prepared by a combined sol-gel and 
chemical vapour deposition (CVD) process. The photocatalytic performance has been 
studied by varying the photocatalyst concentration (from 10 to 40 mg/L), e.g. at 
different cat-to-sub ratios. The changing of the pH solution, the re-use and adsorption 
experiments have been deeply investigated. Additionally, formation of reaction 
intermediates during the oxidative decomposition of the pharmaceuticals: ibuprofen 
and tetracycline has been studied and compared with commercial titania. 
 
Photocatalytic activity 
The photocatalytic performance of Zr-doped titania has been investigated in the 
degradation of ibuprofen and tetracycline. The cat-to-sub ratios were varied by 
changing the photocatalyst concentrations (from 10 to 40 mg/L) at constant pollutant 
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concentration (10 ppm) of both pharmaceuticals.The course of abatements of 
ibuprofen is shown in Figure 22. 
 
 
Figure 22. Photocatalytic abatement of ibuprofen in aqueous solution over Zr-TiO2 photocatalyst under 
UV-Vis irradiation; IBP conc.: 10 ppm, cat conc.: 10, 20 and 40 mg/L. 
  
After a small initial increase after 5 min of photocatalytic treatment, the abatement 
proceeds continuously with time. The faster initial abatement at the onset is probably 
due to the photocatalytic oxidation of IBP at highly reactive electron holes at the 
surface and in part by adsorption. The electron holes have a higher oxidation potential 
compared to electrons (compare Tab. 3). Increased cat-to-sub ratio from 1:1 to 4:1 
enhances the abatement of ibuprofen of up to ca. 90 % due to the presence of more 
active sites, by means, the surface electrons and holes.  
At the same time, formation of intermediates is also increased (Fig. 23). Only with 
high cat-to-sub ratios (photocatalyst in excess) the concentration of intermediates 
decrease after prolonged photocatalytic treatment. However, intermediates did not 
fully disappear even after 180 min (Fig. 23). Although high a percentage of IBP is 
photocatalytic abated over Zr-doped titania, the achieved photocatalytic abatement is 
somewhat lower than observed with titania photocatalysts even the specific surface 
area is markedly increased up to 100 m2/g (compare A 1, Tab. 1). The latter is also 
reflected in the less effective degradation of formed intermediates.     
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Figure 23. Formation of the temporary intermediates of ibuprofen in aqueous solution during 
photocatalytic treatment over Zr-TiO2 photocatalyst based on UV-Vis absorbance at λmax 262 nm for 
different cat conc.: 10, 20 and 40 mg/L, IBP conc.: 10 ppm.  
 
In Table 6 the relative and absolute abatements and corresponding experimental 
effective mean first order reaction rates of ibuprofen over Zr-doped titania derived 
from the abatement curves are summarized. 
 
Table 6. Data of the photocatalytic abatement of ibuprofen (10 ppm) in water during photocatalytic 
treatment over Zr-TiO2 photocatalyst (cat conc.: 10, 20 and 40 mg/L). Relative and absolute 
abatements (A) and corresponding experimental effective mean first order reaction rates (r) calculated 
after 30, 120 and 180 min of treatment. 
irradiation 
time of IBP 
[min] 
rel. A 
[%] 
abs. A 
[mg/L] 
r 
[min -1] 
rel. A 
[%] 
abs. A 
[mg/L] 
r 
[min -1] 
rel. A 
[%] 
abs. A 
[mg/L] 
R 
[min -1] 
10 mg/L 20 mg/L 40 mg/L 
5 5 0.5 0.0100 6 0.6 0.0060 11 1.1 0.0055 
30 12 1.2 0.0040 19 1.9 0.0032 36 3.6 0.0030 
120 35 3.5 0.0029 54 5.4 0.0023 84 8.4 0.0018 
180 56 5.6 0.0031 71 7.1 0.0020 89 8.9 0.0012 
 
As is expected, the relative and absolute abatement increases with reaction time and 
increasing photocatalyst loading (cat-to-sub ratio). However, the absolute abatement 
per mg of photocatalyst decreases with increasing photocatalyst amount. E.g. after 30 
min of treatment, the specific abatements decrease from 0.12, 0.095 and 0.09 mg/L 
IBP per mg of photocatalysts with increased photocatalyst amount from 10 to 40 
mg/L, respectively. Therefore, the mean reaction rates also decrease in the same 
order. The decrease of the mean reaction rate at high photocatalyst loading (40 mg/L) 
between 120 and 180 min of reaction is due to photocatalyst deactivation. The 
abatement increases only slightly. This finding is surprising, because the IBP 
concentration (10 ppm) is low compared to the photocatalyst. Finally, the apparent 
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photocatalyst efficiency is decreased with growing cat-to-sub ratio, but the total 
abatement is improved. Probably, the photocatalyst is faster deactivated by formed 
reaction intermediates. A similar effect is observed with titania after 30 min of 
reaction (Tab. 4). Finally, the abatement over titania is higher (up to 100 %) due its 
high onset activity, which has been ascribed to the presence of highly active electron 
holes.          
The adsorption of ibuprofen over titania and Zr-doped TiO2 is shown in Figure 24. 
The Zr-doping of titania significantly enhanced the adsorption of IBP compared to 
non-doped TiO2.  
 
 
Figure 24. Adsorption of ibuprofen on titania P25 and Zr-TiO2 photocatalysts in the dark; IBP conc.: 
10 ppm, cat conc.: 100 mg/L; (inset) magnification of adsorption curves between 0 and 30 min; cat-to-
sub ratio of 10:1. 
 
Already at short contact time the IBP is adsorbed on Zr-TiO2. Ca. 20 % abatement of 
ibuprofen is achieved by adsorption from a low concentrated solution containing 10 
ppm IBP with 100 mg/L of photocatalyst. This improved adsorption is maintained at 
long contact time of 180 min in aqueous solution. In contrast, adsorption on titania is 
comparably low. The significant enhanced adsorption at Zr-doped titania can be 
explained by both, the increased specific surface area and the presence of 
mesoporosity of 0.25 cm3/g and pores of 8 - 9 nm size (compare A 1.1, Fig. 9) 
compared to the titania photocatalyst.  
 
The photocatalytic abatements of tetracycline over Zr-doped titania photocatalyst 
(10, 20 and 40 mg/L) has been studied at constant concentration of 10 ppm (Fig. 25). 
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The photocatalytic behaviour of the TC abatement is similar to that of IBP, reported 
above. However, the achieved abatement is lower with ca. 37 to 70 % for 10 to 40 
mg/L photocatalyst loading, respectively. The photocatalytic abatement of TC 
increases nearly continuously after the first 5 min of treatment up to 120 min. Beyond 
120 min the abatement proceeds slowly leading to a lower slope of the abatement 
curve especially for higher cat-to-sub ratio of 2 or 4. The photocatalyst deactivation 
observed after 120 min of reaction increases markedly with the increased cat-to-sub 
ratios.  
 
 
Figure 25. Photocatalytic abatement of tetracycline in aqueous solution over Zr-TiO2 photocatalyst 
under UV-Vis irradiation; TC conc.: 10 ppm, cat conc.: 10, 20 and 40 mg/L. 
 
The mean first order reaction rates of TC and IBP are similar and decrease with 
increasing reaction time and photocatalyst amounts (Tab. 7).  
 
Table 7. Data of the photocatalytic abatement of tetracycline (10 ppm) in water during photocatalytic 
treatment over Zr-TiO2 photocatalyst (cat conc.: 10, 20 and 40 mg/L). Relative and absolute 
abatements (A) and corresponding experimental effective mean first order reaction rates (r) calculated 
after 30, 120 and 180 min of treatment. 
irradiation 
time of TC 
[min] 
rel. A 
[%] 
abs. A 
[mg/L] 
r 
[min -1] 
rel. A 
[%] 
abs. A 
[mg/L] 
r 
[min -1] 
rel. A 
[%] 
abs. A 
[mg/L] 
r 
[min -1] 
10 mg/L 20 mg/L 40 mg/L 
5 4 0.4 0.0080 5 0.5 0.0050 8 0.8 0.0040 
30 11 1.1 0.0036 15 1.5 0.0025 30 3 0.0025 
120 30 3 0.0025 50 5 0.0020 64 6.4 0.0013 
180 37 3.7 0.0021 55 5.5 0.0015 70 7 0.0009 
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Zr-doped TiO2 shows lower abatements in the abatement of tetracycline due to the 
lower onset activity (Fig. 26). Contrary to, the high onset activity of titania is due to 
improved photocatalytic activity. Zr-doped titania, is markedly contributed by 
absorption, at the onset abatement, due to the improved adsorption properties.     
 
Figure 26. Photocatalytic abatement of tetracycline in aqueous solution over titania P25 and Zr-TiO2 
photocatalysts under UV-Vis irradiation; TC conc.: 20 ppm, cat conc.: 20 mg/L.  
 
Influence of pH solution 
The photocatalytic abatement of ibuprofen over Zr-TiO2 photocatalyst is significantly 
improved with decreasing pH value. Rapid photocatalytic abatement is observed at 
the very beginning of the treatment (5 min), especially at acidic conditions. It 
increases by a factor of 6 with simultaneous decreasing the pH value from 9 to 2. 
Thereafter, degradation of ibuprofen proceeds continuous, but slower, as was already 
noted (Fig. 27).  
 
Figure 27. Influence of pH value of the reaction solution on the photocatalytic abatement of ibuprofen 
in aqueous solution over Zr-TiO2 photocatalyst under UV-Vis irradiation; IBP conc.: 20 ppm, cat 
conc.: 10 mg/L. 
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The noticeable improvement of the photocatalytic activity is explained by the changed 
surface properties of titania after Zr-doping. Obviously, the material behaves more 
hydrophobic. Therefore, non - polar molecules are preferentially adsorbed. The 
dissociation of the carboxylic acid group of ibuprofen is diminished with decreasing 
pH value, because ibuprofen is a weak acid (pKa = 4.4). This will favour the 
interaction of the IBP with the photocatalyst surface. Alignment of IBP molecules on 
the photocatalyst surface and in solution can be improved by hydrogen bonding 
between non - dissociated carboxyl groups. This effect can markedly enhance the 
adsorption/enrichment of the substrate at the photocatalyst surface. The self -
agglomeration tendency of IBP is also shown by the formation of agglomerated 
species in the starting reaction solution. The polar hydrophilic intermediates, that are 
formed, are readily released from the hydrophobic photocatalyst surface into solution.  
 
The influence of the pH value of the tetracycline solution on the activity of Zr-doped 
titania (Zr-TiO2) photocatalyst has been also checked (Fig. 28).  
 
 
Figure 28. Influence of pH value of the reaction solution on the photocatalytic abatement of 
tetracycline in aqueous solution over Zr-TiO2 photocatalyst under UV-Vis irradiation; IBP conc.: 20 
ppm, cat conc.: 10 mg/L. 
 
In contrast to ibuprofen, the influence of the pH value of the reaction solution is low 
showing the importance of the nature of the substrate molecule. At all three pH values 
applied, the tetracycline is mainly ambivalent charged (compare A 1.2, Fig. 30). 
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The variation of the pH value does not change the general finding that the 
photocatalytic degradation of IBP and TC proceeds faster over titania and that 
ibuprofen IBP is easier converted than tetracycline.  
 
Formation of ibuprofen intermediates 
The photocatalytic decomposition behaviour of ibuprofen over Zr-TiO2 was followed 
by UV-Vis spectroscopy based on the intensity of the 222 nm absorbance of the 
aromatic ring of IBP. The decrease of this absorption band during photocatalytic 
treatment is accompanied by the simultaneous appearance and increase of a new 
absorbance at 262 nm, which has been used to characterize the formation of reaction 
intermediates.  ESI-TOF-MS measurements (after 30 and 240 min of treatment) have 
been performed to detect qualitatively the formation of different types of 
intermediates. 
Figure 29 shows the corresponding UV-Vis spectra of reaction solutions after 
different reaction times. During the course of treatment, IBP is decomposed as 
indicated by the decrease of the 222 nm absorbance of IBP. The decrease of the 222 
nm band is related to the cat-to-sub ratio in the order 1:1 < 2:1 < 4:1, with increased 
photocatalyst amount. At the same time, the formation of intermediates is increased 
and is higher with increased photocatalyst amount. However, after 180 min of 
reaction the concentration of intermediates is decreased again due to the ongoing 
photocatalytic degradation 
a) 
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b) 
 
c) 
 
Figure 29. UV-Vis spectra of an aqueous ibuprofen solution after photocatalytic treatment over Zr-
TiO2 photocatalyst at different cat-to-IBP ratio a) 4:1; b) 2:1; c) 1:1 under UV-Vis irradiation: (1) 
starting IBP solution (10 ppm) and after (2) 5 min, (3) 30 min, (4) 60 min, (5) 120 min, (6) 180 minutes 
of photocatalytic treatment. Concentration of ibuprofen determined based on the absorbance at 222 nm. 
Experimental conditions: IBP conc.: 10 ppm, cat conc.: 10, 20 and 40 mg/L, pH=7. 
 
Additionally, ESI-TOF-MS measurements were carried out to follow the ibuprofen 
decomposition process (Fig. 30). Beside the m/z 205 peak related to the ibuprofen 
anion, higher mass-to-charge peaks are observed at m/z 433, 661 and 889 in the 
starting solution (compare A 1.2, Fig. 34). These peaks indicate the presence of 
agglomerated IBP species. The mass increment of 228 between the signals at m/z 205 
and m/z 433, 661 and 889 indicates ibuprofen sodium salt units. Some impurities, e.g. 
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at m/z 273 and corresponding agglomerated species of ibuprofen sodium salt, as 
indicated by peaks arising at m/z 501 and 729, are also observed in ESI-TOF-MS 
spectrum.  
In the case of chemical bonding by C - C coupling of IBP (formation of polymers), 
the mass increments between the peaks would lower due to the release of hydrogen 
atoms. Therefore, these species (Fig. 30 a) should be aggregates of IBP and the 
impurity (m/z 273) held together by ionic interactions between the negatively charged 
carboxylic groups and the sodium ions and by non - polar interactions between the 
hydrophobic tails of the ibuprofen molecules. These aggregates are decomposed by 
photocatalytic treatment (Fig. 30 b). After 30 min of photocatalytic treatment, the m/z 
peak intensities of agglomerated species decrease markedly. IBP is still present as 
indicated by the peak of the ibuprofen anion at m/z 205 [M-H]-.  
Additional peaks appear at higher and lower m/z values. Obviously, they belong to 
photocatalytic oxidation and decomposition products.  
 
a) 
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b) 
  
Figure 30. Negative ESI-TOF-MS spectrum of the aqueous ibuprofen solution after a) 30 min and b) 
240 min of photocatalytic treatment over Zr-TiO2 photocatalyst under UV-VIS irradiation; IBP conc.: 
20 ppm, cat. conc.: 20 mg/L. 
 
The possible oxidation by-products of ibuprofen of higher masses are due to side 
chain hydroxylation and carboxylation as initial oxidation processes. Lower mass 
products are formed by dimethylation and decarboxylation combined with 
hydroxylation during oxidation. Accordingly, the observed higher mass m/z [M-H]- 
peaks at 221, 251 and higher are assigned to hydroxy ibuprofen (221), carboxylated 
hydroxyl ibuprofen (251) and related different side chain oxidation products (Scheme 
2). Such oxygenated species decompose readily under photocatalytic conditions.  
It is concluded that the observed higher mass molecule fragments (m/z > 300) point to 
the formation of polymeric species. They can be formed from phenols, alcohols or 
aldehydes present in the reaction solution giving rise to lower mass peaks m/z < 205. 
For example, the [M-H]- peak at (133) could be due to formation of 4-
ethylbenzaldehyde or 2-methyl-1-phenylpropane, (149) to 4-isobutylphenol, (163) to 
4-acetylbenzoic acid, (175) to 4-isobutylacetophenon or 4-(hydroxyisobutyl)ethyl 
benzene, (177) to 1-(isobutylphenyl)-1-ethanol and others.[182-185] 
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Scheme 2. Possible formation of side-chain products, its deep oxidation products and open ring 
intermediates formed during photocatalytic abatement of ibuprofen.  
 
Even after an extended treatment time of 240 min (Fig. 30 b), ibuprofen is not fully 
converted as indicated by the presence of the ibuprofen anion peak at m/z 205. A 
couple of intermediate decomposition products are still present in the reaction 
solution, which were not mineralized. They give rise to a variety of signals in the ESI-
TOF-MS spectrum of the photocatalytic treated solution. The lower mass peaks at m/z 
<205 are expected to belong to oxidation products like phenols or ketones and others 
as discussed above.[182,184,186,187] These peaks show the presence of some aromatics 
and reaction intermediates, giving rise to absorbance bands at 222 nm and 262 nm, 
respectively. 
Additionally, new signals appear after photocatalytic treatment at higher m/z values of 
277, 291, 305 and 319 (Fig. 30 b). The observed mass differences, with constant 
increments of 14, implies that they likely represent methyl substitutes of the 
compound giving rise to the m/z 277 signal. It is proposed that they belong to trimeric 
quinonic compounds as shown schematically in Equation 19. 
 
        (19) 
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This proposal is supported by recent studies. They show the possibility of the 
polymerization of aromatics, e.g. phenols, in low concentrated aqueous solution 
catalysed by peroxidase enzyme.[188-190] The observation of oligomeric species during 
photocatalytic treatment of ibuprofen is new and has been found with titania 
photocatalyst, recently for the first time.[191]  
 
For comparison, the negative ESI-TOF-MS spectra of the aqueous ibuprofen solution 
after 30 and 240 min of photocatalytic treatment over titania P25 photocatalyst are 
shown in Figure 31. 
 
a)
 
b) 
 
Figure 31. Negative ESI-TOF-MS spectrum of the aqueous ibuprofen solution after a) 30 min and b) 
240 min of photocatalytic treatment over titania P25 photocatalyst under UV-VIS irradiation; IBP 
conc.: 20 ppm, cat. conc.: 20 mg/L. 
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After 30 min of photocatalytic treatment, mass signals of oligomerics products of the 
staring solution disappear (Fig. 31 a). Besides, the ibuprofen anion peak [M-H]¯ at m/z 
205, peaks at m/z 221, 251, 277, 305, 319 and others appear. Obviously, these higher 
molecular mass peaks belong to partial oxidation products of IBP and reaction 
products of intermediates e.g. the m/z 221 and 251 peaks, which belong to side - chain 
oxidation products, which have been identified by Méndez - Arriaga, Caviglioli and 
Madhavan.[182,184,187]  
Lower mass [M-H]- peaks arising at m/z 146, 133, 129 and lower likely belong to 
deeper oxidized degradation products like aromatic ketones, carboxylic acids or 
phenols. It has to be noted that at this point, the 262 nm absorbance in the UV-Vis 
spectrum related to intermediates reaches maximum intensity (Fig. 32). After 240 min 
of photocatalytic treatment, the m/z 205 peak of the IBP anion disappeared 
completely. In addition, the intensities of lower m/z peaks decreased substantially. 
Low intense peaks at m/z 117 and 129 remained probably belonging to aromatic 
oxidation products. Interestingly, new peaks of higher molecular mass appear at m/z 
277 as well as 291 and 305 (Fig. 31 b). The mass differences of 14 between these 
peaks points to methyl substitution. It is proposed that these peaks belong to 
oligomerization products of aromatics compounds like phenols formed during the 
photocatalytic decomposition of IBP. These peaks start to arise already after 30 min 
of photocatalytic treatment. 
These data indicate that the photocatalytic properties of Zr-TiO2 and TiO2 differ. In 
case of Zr-TiO2 more reaction by - products are present in photocatalytic treated 
solutions. The comparison shows that reaction intermediates formed over titania are 
almost successively decomposed during the course of photocatalytic treatment (Fig. 
8). Finally, mainly polymeric species remain in the reaction solution. In contrast, 
formed reaction intermediates are more difficult to decompose over Zr-TiO2. 
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Figure 32. Formation of the temporary intermediates of ibuprofen in aqueous solution during 
photocatalytic treatment over titania 25 and Zr-TiO2 photocatalyst based on UV-Vis absorbance at λmax 
262 nm; IBP conc.: 20 ppm, cat conc.: 20 mg/L.  
 
Formation of tetracycline intermediates 
The formation of TC intermediates over Zr-TiO2 and titania and has been studied by 
ESI-TOF-MS measurements (Fig. 33-35). The negative ESI-TOF-MS spectrum of 
starting tetracycline solution is shown in Figure 33. The starting solution exhibits one 
main peaks located at m/z 443 nm related to the tetracycline [M-H]- peak. Other 
present molecular peaks at ca. m/z 155, 501 and 909 indicate some impurities.  
 
 
Figure 33. Negative ESI-TOF-MS spectrum of the starting aqueous tetracycline solution (20 ppm).   
 
After 30 min of photocatalytic treatment over Zr-TiO2, the main mass-to-charge peak 
[M-H]¯ of the TC still appears at m/z 443 (Fig. 34). Besides, some new lower 
molecular mass-to-charge peaks are observed around ca. m/z 170, and very low 
intense peaks around m/z 130 - 140 and<100. After 240 min an additional m/z peak 
arises at ca. m/z 265.  
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Scheme 3. Proposed possible formation of ring opening tetracycline intermediates (i.g. three, two and 
one ring aromatics[192] followed by formation of aliphatic compounds (i.g. aliphatic acids, alcohols, 
ethers).  
 
According to Zhu and Niu[177,193] the degradation of TC, consisting  of four aromatic, 
olefinic and aliphatic 6-membered hydrocarbon rings, proceeds via non-selective 
oxidation of the non-aromatic part producing reaction intermediates through ring 
opening. This way mainly substituted aromatics based on benzenes are formed 
probably via quinone formation (Scheme 3).  
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As a results, a couple of different intermediates of medium mass (m/z < 210) related 
to anthraquinone, quinone derivates,[194] benzoic acid derivates, substituted benzene 
and phenol derivates are formed and further decomposed to low mass (m/z <100) 
aliphatic acids, alcohols and ethers. 
 
a) 
 
 
b) 
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Figure 34. Negative ESI-TOF-MS spectrum of the aqueous tetracycline solution after a) 30 min and b) 
240 min of photocatalytic treatment over Zr-TiO2 photocatalyst under UV-VIS irradiation, including 
higher magnifications (given below); TC conc.: 20 ppm, cat conc.: 20 mg/L. 
 
ESI-TOF-MS data reveal incomplete abatement of TC over Zr-doped titania and 
formation of minor amounts of reaction intermediates, which are not decomposed 
even after 240 min of photocatalytic treatment. The findings are confirmed by the 
results of the photocatalytic abatement studies under similar conditions (Fig. 25). 
They degradation curve shows that only ca. 53 % of tetracycline is abated over Zr-
doped titania after 240 min of treatment.    
For comparison, ESI-TOF-MS measurements have been performed for the 
photocatalytic decomposition of tetracycline over titania P25 (Fig. 35). After 30 min, 
distinctly more tetracycline is converted compared to the Zr-doped titania 
photocatalyst. The intensity (counts) of the TC related peak at m/z 443 is decreased. 
Additionally, a couple of by - products with m/z < 170 are formed. However, the peak 
intensities are low. After 240 min of treatment, the TC is markedly diminished 
showing as indicated by the low intensity of the corresponding m/z peak, which is in 
the same order of magnitude as the intermediates. Indeed, the photocatalytic testing 
shows ca. 95 % of degradation of TC after four hours of treatment. A broad 
distribution of low concentrated different reaction intermediates given rise to signals 
in the m/z range between 200 and 50 are present in the solution, indicating deeper 
oxidation of TC over titania. Additionally, m/z peaks at 265, 277, 291, 309 and 325 
are observed, which might be related to substituted anthraquinones and 
hydroquinones[195] (structures containing three six - membered rings). 
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a) 
 
 
b) 
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Figure 35. Negative ESI-TOF-MS spectrum of the aqueous tetracycline solution after a) 30 min and b) 
240 min of photocatalytic treatment over titania P25 photocatalyst under UV-VIS irradiation, including 
higher magnifications (given below); TC conc.: 20 ppm, cat conc.: 20 mg/L. 
 
The ESI-TOF-MS measurement shows that the spectrum of formed intermediates 
over Zr-doped and non-doped titania are different compared to the data given in the 
literature.[177,193] Fewer types of intermediates are formed with Zr-doped titania. This 
might be due to its lower photocatalytic activity (Fig. 34 b and 35 b). In contrast to 
ibuprofen, the photocatalytic degradation of the large polyketide tetracycline results in 
the formation of a couple of aromatic intermediates.  
 
Re-use experiments 
The photocatalytic activity of Zr-TiO2 has been checked in re-use experiments during 
abatement of ibuprofen (10 mg/L of photocatalyst per 10 ppm of IBP) under neutral 
reaction conditions using cycling experiments. Decomposed IBP was replaced by 
fresh IBP portion.  
The achieved abatement of ibuprofen decreased from ca. 55 % in the first run to 21 % 
and 19 % in the second and third run, respectively (Fig. 36). The photocatalyst 
deactivation is highest after the first run indicating the blocking of most active sites.  
Indeed, formation of reaction intermediates is found after the first run (Fig. 37) and 
increases with the cycling experiments. This indicates incomplete decomposition of 
the IBP followed by cycling experiments. 
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Figure 36. Photocatalytic abatement of ibuprofen in aqueous solution over Zr-TiO2 photocatalyst under 
UV-Vis irradiation after 3 runs of treatment; IBP conc.: 10 ppm, cat conc.: 10 mg/L. 
 
 
 
Figure 37. Formation of the temporary intermediates of ibuprofen in aqueous solution during 
photocatalytic treatment over Zr-TiO2 photocatalyst based on UV-Vis absorbance at λmax 262 nm after 3 
runs of treatment; IBP conc.: 10 ppm, cat conc.: 10mg/L. 
 
The photocatalytic abatements of tetracycline over Zr-TiO2 was investigated in 3 
runs of photocatalytic treatment (Fig. 38). The cycling experiment shows that the 
photocatalyst can be re-used also in the case of tetracycline. However, as is generally 
observed, the abatement decreases with the cycling. 
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Figure 38. Photocatalytic abatement of tetracycline in aqueous solution over Zr-TiO2 photocatalyst 
under UV-Vis irradiation after 3 runs of treatment; TC conc.: 10 ppm, cat conc.: 10 mg/L. 
 
The final comparison of the re-use experiments with ibuprofen and tetracycline over 
non - doped and Zr-doped titania is shown in Figure 39. Both materials are subject of 
the photocatalyst deactivation during cycling (re-use) experiments. The deactivation is 
more pronounced with Zr-doped titania. The decomposition of formed reaction 
intermediates is more efficient over titania, probably by the reducing of photocatalyst 
poisoning.  
 
a) b)  
Figure 39. Representative graphs of the photocatalytic abatements of ibuprofen and tetracycline over a) 
Zr-TiO2 and b) titania after 180 min of treatment in 3 runs under UV-Vis irradiation; TC and IBP 
conc.: 10 ppm, cat conc.: 10 mg/L. 
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Summary  
 The impact of the titania doping with zirconium on the photocatalytic activity 
has been checked during the course of ibuprofen and tetracycline abatement 
and compared with commercial titania P25. 
 The doped material showed lower onset activity compared to titania P25.  
 The lower onset activity is followed by faster composition, due to higher 
adsorption. The contribution of adsorption significantly increases what is 
attributed to higher specific surface area (100 m3/g) and the presence of 
mesoporosity.  
 The deactivation in the second stage of reaction (between 30 and 180 min) is 
lower compare to titania. The reaction rates of Zr-TiO2 amount ca. 0.0036 and 
0.0022 for the IBP and TC abatements, respectively. 
 The change pH value of solution influences the ibuprofen degradation. The 
best photocatalytic abatement of IBP over Zr-TiO2 is observed at acidic 
conditions. This finding is explained by more hydrophobic character of Zr-
doped titania and therefore increased affinity toward non-polar IBP molecule. 
In contrast, the variation of pH value of TC solution does not change the 
ambivalent character of TC molecule. 
 Zr-doped titania forms more IBP intermediates. Especially, after 240 min of 
treatment a couple of oligomeric species are observed in the solution 
(intermediates with lower masses). In contrast, the degradation of IBP over 
titania proceeds faster and more effective (the spectrum seems to be more 
clean). The ESI-TOF-MS spectra of TC show incomplete decomposition. A 
lot of minor TC intermediates are formed. After 240 min of treatment, these 
by-products are still present. A couple of different TC intermediates of 
medium masses are related to anthraquinone derivates. 
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3.3. Photocatalytic abatement of low concentrated (ppb-low 
ppm) tetracycline over novel titania based photocatalysts 
 
Novel titania (Ti) - based photocatalysts as doped titania, titania nanotubes (TNs), 
metal-organic framework based photocatalysts namely Ti/MIL-101 composites and 
MIL-125 have been investigated in the photocatalytic degradation of very low 
concentrated (0.1 or 0.5 ppm) antibiotic tetracycline from aqueous solution. The aim 
was to test whether improved adsorption properties of these porous materials and 
enhanced use of visible light, in the case of doped titania and the Ti/MIL-101 
composite, will facilitate the photocatalytic degradation.  
 
Photocatalytic abatement of tetracycline over titania and titania doped materials 
(Zr-TiO2, Fe-TiO2 and N-TiO2) 
Photocatalytic testing of titania doped materials (Zr-TiO2, Fe-TiO2 and N-TiO2) was 
checked during decomposition of tetracycline in very low concentration (500 ppb). 
The course of photocatalytic abatements shows the contribution of power of the UV-
Vis solarium lamp, with part of solar (visible) range, on the decomposition of 
tetracycline in low concentrated solution. 
Figure 40 shows the course of photocatalytic abatement of tetracycline over 
commercial titania photocatalyst. It has to be noticed that this experiment has been 
performed at very low catalyst concentration (2 mg/L) and low cat-to-sub ratio of 4. 
As is observed, with higher concentrated solution (compare Chapter 3.1), rapid 
degradation occurs at the onset of reaction (initial 1st stage), followed by continuous 
but slowly abatement between 10 and 60 min. Ca. 70 and 90 % of abatement of 
tetracycline has been achieved after 10 and 60 min, respectively.   
At low pollutants concentration of 500 ppb increase of electric power has no impact 
on the photocatalytic abatement. Obviously, low pollutants concentration requires 
only weak radiation power, which allows for application of sunlight. Also blank 
irradiation tests in the absence of the photocatalyst were carried out in order to check 
a possible contribution of photolysis. The TC concentration was diminished by only 
10 % after 3 hours of irradiation.  
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Additionally, adsorption experiments were carried out with photocatalysts in the dark. 
Figure 41 shows the photocatalytic treatment of tetracycline over titania photocatalyst 
and the corresponding adsorption. Clearly, adsorption contributes significantly to the 
abatement at low pollutant concentration. Especially, at the onset of reaction the 
adsorption is high on the titania photocatalyst (ca. 30 %), which is different from the 
behaviour at high ppm pollutant concentration.  
 
 
Figure 41. Adsorption and photocatalytic abatement of tetracycline in aqueous solution over titania 
P25 photocatalyst; TC conc.: 500 ppb, cat. conc.: 2 mg/L, cat-to-sub ratio of 4. 
 
The influence of the dopant of titania e.g. with zirconium (Zr-TiO2), iron (Fe-TiO2) 
and the nitrogen (N-TiO2) has been tested on the photocatalytic abatement of 
tetracycline. The courses of photocatalytic abatement of TC at low concentration and 
corresponding adsorption curves are shown in Figures 42-44. 
 
 
Figure 42. Adsorption and photocatalytic abatement of tetracycline in aqueous solution over Zr-TiO2 
photocatalyst; TC conc.: 500 ppb, cat. conc.: 2 mg/L, cat-to-sub ratio of 4. 
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Figure 43. Adsorption and photocatalytic abatement of tetracycline in aqueous solution over Fe-TiO2 
photocatalyst; TC conc.: 500 ppb, cat. conc.: 2 mg/L, cat-to-sub ratio of 4. 
 
 
Figure 44. Adsorption and photocatalytic abatement of tetracycline in aqueous solution over N-TiO2 
photocatalyst; TC conc.: 500 ppb, cat. conc.: 2 mg/L, cat-to-sub ratio of 4. 
 
In the initial stage of treatment, after 10 min, ca. 50 % of abatement is achieved with 
all the doped titania photocatalysts. Further prolongation of the treatment time  
enhances the abatement over Zr-doped TiO2 and very slightly in the case of Fe-TiO2 
and N-TiO2 (Fig. 43 and 44). In all cases, adsorption contributes significant to the 
abatement (ca. 30-40 %), The high contribution of adsorption found with doped 
materials is due to the improved mesoporosity and enhanced surface area of ca. 100-
180 m2/g compared to ca. 55 m2/g of the non-doped titania. Zr-TiO2 exhibits a 
distinctly higher onset activity and adsorption.  
 
The contribution of adsorption of low concentrated TC solution has been summarized 
in Table 8. The observed tetracycline up-takes of up to 90 µg per mg of photocatalyst 
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exceed the estimated monolayer coverage of TC on titania of ca. 15 µgTC/mgcat. These 
high up-takes can be achieved by multilayer adsorption or in the confined space of the 
mesopores. It has to be noticed that the adsorption is much lower at higher 
concentration (ppm range) even at similar reaction conditions and cat-to-sub ratio. 
Obviously, at very low concentration (ppb range) the adsorption of TC on the 
photocatalyst surface by vertical alignment is preferred, compared to molecular 
solution in the water. This might be due to the hydrophobic part of the flat TC 
molecule limiting hydration.  
 
At higher concentration, beyond the critical micelle formation concentration (CMC) 
or aggregate formation concentration (aggregation concentration, ca. 44 ppm range), 
formation of aggregates[196] may facilitate solution competing with decreased 
adsorption of TC at the photocatalyst surface.    
 
Table 8. Data of the adsorption of low concentrated tetracycline solution (0.5 ppm) over titania and 
titania doped photocatalysts (cat conc.: 2 mg/L). Relative and absolute adsorption data (A) and 
corresponding photocatalyst loading calculated after 5, 30 and 60 min of treatment; cat-to-sub ratio of 
4:1. 
Adsorption of low TC concentration ( 0.5 ppm) 
adsorption 
time of TC 
[min] 
rel. A 
[%] 
abs. A 
[mg/L] 
loading 
[mg/mg] 
rel. A 
[%] 
abs. A 
[mg/L] 
loading 
[mg/mg] 
titania Zr-TiO2 
5 21 0.1050 0.0525 26 0.1300 0.0650 
30 16.1 0.0805 0.0403 37.5 0.1865 0.0938 
60 14.3 0.0715 0.0357 48.6 0.243 0.1251 
adsorption 
time of TC 
[min] 
rel. A 
[%] 
abs. A 
[mg/L] 
loading 
[mg/mg] 
rel. A 
[%] 
abs. A 
[mg/L] 
loading 
[mg/mg] 
Fe-TiO2 N-TiO2 
5 9 0.045 0.0225 11 0.0550 0.0275 
30 47.6 0.238 0.1190 38 0.1900 0.0950 
60 45.2 0.226 0.1130 29 0.1450 0.0725 
 
The relative and absolute photocatalytic abatements of tetracycline in the ppb 
concentration range over titania, Zr-TiO2, Fe-TiO2 and N-TiO2 photocatalysts and 
corresponding experimental effective mean first order reaction rates (r) calculated 
after 5, 30 and 60 min of treatment are summarized in Table 9.  
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Table 9. Data of the abatement of low concentrated tetracycline solution (500 ppb) during 
photocatalytic treatment over titania and titania doped photocatalysts (cat conc.: 2 mg/L). Relative and 
absolute abatements (A) and corresponding experimental effective mean first order reaction rates (r) 
calculated after 5, 30 and 60 min of treatment; cat-to-sub ratio of 4:1. 
Low concentration of TC (500 ppb) 
irradiation 
time of TC 
[min] 
rel. A 
[%] 
abs. A 
[mg/L] 
r 
[min -1] 
rel. A 
[%] 
abs. A 
[mg/L] 
r 
[min -1] 
titania Zr-TiO2 
5 48.8 0.244 0.0244 47 0.235 0.0235 
30 76.2 0.381 0.0063 53.2 0.266 0.0044 
60 84.4 0.422 0.0035 67.8 0.339 0.0028 
irradiation 
time of TC 
[min] 
rel. A 
[%] 
abs. A 
[mg/L] 
r 
[min -1] 
rel. A 
[%] 
abs. A 
[mg/L] 
r 
[min -1] 
Fe-TiO2 N-TiO2 
5 26 0.13 0.013 31.6 0.158 0.0158 
30 55.8 0.279 0.0047 56 0.28 0.0047 
60 55.8 0.279 0.0023 60 0.3 0.0025 
High concentration of TC (10 ppm) 
irradiation 
time of TC 
[min] 
rel. A 
[%] 
abs. A 
[ 
mg/L] 
r 
[min -1] 
rel. A 
[%] 
abs. A 
[mg/L] 
r 
[min -1] 
titania Zr-TiO2  
5 34.5 3.45 0.0173 10.9 1.09 0.0055 
30 68.4 6.84 0.0057 36.8 3.68 0.003 
60 86.8 8.68 0.0036 59.8 5.98 0.0025 
 
The initial photocatalytic abatement rates are higher for titania and distinctly lower for 
the doped titania photocatalysts. They decrease with reaction time due to the 
deactivation of the photocatalysts in the TiO2, Zr-TiO2, Fe-TiO2 and N-TiO2. The 
photocatalytic abatement rates of the initial stage (5 min) over titania and Zr- TiO2 
obtained with low tetracycline concentration (0.5 ppm) have been compared with that 
of high TC concentration (10 ppm), but at the same cat-to-sub ratio of 4:1 (Tab. 9). 
The abatement rates achieved at low concentration are markedly higher than those 
found at high concentration (10 ppm), even the cat-to-sub ratio is equal (Fig. 45). This 
finding is in line with the adsorption data, which showed enhanced specific adsorption 
at low concentration (ppb range).  
It is concluded that the increased adsorption and therefore, enrichment of the substrate 
the at photocatalyst surface, facilitates the photocatalytic degradation.  
On the catalyst surface the reactive oxidative species e.g. hydroxyl radicals (•OH) and 
superoxide radicals (O2
-•) as well as electron holes (h+) are formed.     
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Figure 45. Comparison of the mean experimental first order reaction rates of tetracycline abated at low 
(ppb) and high (ppm) concentred solutions over titania, Zr-TiO2, Fe-TiO2 and N-TiO2 photocatalysts, 
estimated after 5 min of treatment, cat-to-sub ratio of 4:1. 
 
Photocatalytic abatement of tetracycline over new porous titania-based 
photocatalysts  
Beside titania and doped titania photocatalysts, the photocatalytic abatement of low 
concentrated tetracycline solution (100 ppb) has been tested also over new ordered 
porous titania based materials as titania nanotubes, titania/MOF MIL-101 composite 
as well as a the titanium containing porous metal - organic framework MIL-125. The 
photocatalytic tests were carried out with 100 ppb TC solution and 0.2 mg of 
photocatalyst. In order to differentiate between adsorption and photocatalytic 
degradation in one experiment, the reaction solution containing the TC and the 
photocatalysts were stirred in the dark (adsorption part) and then irradiated with the 
UV-Vis light (photocatalytic part).  
The photocatalytic abatement of tetracycline over titania and titania nanotubes from a 
100 ppb aqueous solution is shown in Figure 46. After 30 min of adsorption ca. 40 % 
of TC are adsorbed over as-synthesised TNs, and then the photocatalytic treatment 
was started (switching on the UV-Vis solarium lamps).  
The abatement is increased up to ca. 60 % after 60 min of irradiation and slightly 
increases to ca. 66 % after 180 min.  
The calcination of nanotubes at 700°C improves the adsorption as well as the 
photocatalytic activity (Fig. 46). The adsorption is increased to ca. 60 % compared to 
the as-synthesized TN sample. After 60 min of irradiation the abatement increases to 
ca. 74 % and reaches 90 % after 180 min. Although the specific surface area is 
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decreased after calcination from ca. 220 to 100 m2/g,, the adsorption is enhanced by 
ca. 50 % compared to the as-synthesized ones.  
 
 
Figure 46. Adsorption (in the dark) and photocatalytic abatement of tetracycline in aqueous solution 
over as-synthesized titania nanotubes (TNs), calcined nanotubes (TN_700) and titania; TC conc.: 100 
ppb, cat. conc.: 0.2 mg/L, cat-to-sub ratio of 2. 
 
The specific loading per area is increased by a factor of four. TEM images show that 
titania needles are changed to more compact, different shaped nanoparticles resulting 
in the decrease of the specific surface area (compare A 1.1, Fig. 22 and 23). 
The markedly enhanced specific loading (adsorption of TC) points to a change in the 
nature of the surface. The inspection of samples by XPS showed that the un-calcined 
TNs contain much more Ti-OH groups than the calcined ones. The latter is in part 
converted to anatase, rutile and unidentified phases (compare A 1.1, Fig. 21).  
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Figure 47. XPS of Ti2p states of titania nanotubes: (top) as-synthesized and (bottom) calcined. 
 
The intensity of the Ti2p doublet signal at 462.82 eV related to Ti of TiO6 octahedra is 
increased on the expense of the signal at 464.57 eV, assigned to titania connected with 
OH groups (Fig. 47). At the same the O1s signal of TiO6 octahedra at 530.95 eV is 
increases and the corresponding -OH group signal at 533.96 eV is substantially 
decreased (Fig. 48). Calcination results in condensation of the titania network, leading 
to a markedly decrease of the hydrophilic nature of the catalyst, resulting in a 
decreased affinity to water and improved adsorption of TC. 
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Figure 48. XPS of O1s states of titania nanotubes: (top) as-synthesized and (bottom) calcined. 
 
The increase in the photocatalytic activity is due to the formation of anatase, which is 
known to be a photocatalytic active titania phase. 
For the comparison, titania P25 photocatalyst has been included. After 30 min of 
reaction, ca. 65 % of TC is adsorbed. Titania nanoparticles are very effective in the 
photocatalytic abatement of TC (Fig. 46). They show nearly 100 % of abatement of 
TC from low concentrated solution after 90 min of treatment. These findings confirm 
the importance of the formation of anatase for photocatalytic properties of the 
calcined TNs. Therefore, the construction of titania nanotubes consisting of anatase is 
a challenge.  
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The photocatalytic abatement of tetracycline over titania/MIL-101 composites and 
MIL-125 is shown in Figure 49. Adsorption of tetracycline over titania/MIL-101 
composite reached ca. 40 % and increase with adsorption time and the increased 
titania content. Irradiation enhances the abatement of TC by photocatalytic 
degradation. Ca. 40 % of abatement is achieved after 60 min and increases to ca. 65 
and 80 % after 6 hours of treatment for the 6.6 and 10.94 wt.% of Ti containing 
samples, respectively (Fig. 49). The photocatalytic activity is lower than that of the 
titania nanotubes. However, it should be taken into account that the active titania 
content is much lower and is not compensated by a contribution of the MOF 
chromium. 
 
The MIL-125 photocatalyst shows a similar behaviour, but the adsorption is 
somewhat higher (ca. 50 %) due to the high porosity of this porous metal-organic 
framework material. The TC abatement reached ca. 60 % by photocatalytic treatment 
of 60 min and increased slightly to ca. 80 % after 360 min (Fig. 49). The results 
confirm that titania MOFs are promising new porous materials for photocatalytic 
applications. 
  
 
Figure 49. Adsorption and photocatalytic abatement of tetracycline in aqueous solution over MIL-125 
and Ti/MIL-101 photocatalysts; TC conc.: 100 ppb, cat. conc.: 0.2 mg/L, cat-to-sub ratio of 2; Ti 
percent weight (wt. %) of 6.6 and 10.94. 
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Summary  
 New titania based photocatalytic materials (titania doped, titania nanotubes 
and titania/MOF composites) with improved texture and porosity have been 
tested in the degradation of low concentrated tetracycline solution. 
 All doped titania photocatalysts show high initial photocatalytic abatement of 
tetracycline at low concentration (500 ppb) of ca. 55 % after 10 min of 
reaction.  
 Abatement of TC over titania at low ppb range at the same cat-to-sub ratio 
proceeds faster compared to high concentration range (ppm). Ca. 65 % and 35 
% is removed from solution in ppb and ppm range, respectively. The improved 
adsorption at low concentration is due to formation of TC micelles (beyond 
CMC, below 44 ppm), which is preferred to TC self-aggregation in solution. 
This close contact of TC micelles facilitates the high adsorption.  
 The adsorption might be also explained by improved texture, porosity 
(mesoporosity) and higher specific surface area of titania/MOF and nanotubes 
(ca. 100-180 m2/g compared to 55 m2/g for titania).  
 The texture of titania nanotubes after calcinations was changed. Resulted 
increase in the photocatalytic activity of TNs is due to the formation of anatase 
phase at 700°C. This confirms the importance of the anatase presence for the 
photocatalytic activity.  
 Porous titania containing MOFs are also promising photocatalytic materials, 
due to high adsorption and stable increase in the abatement with treatment 
time. 
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3.4. Photocatalytic abatement of ibuprofen and tetracycline 
over two types of nanosized ZnO photocatalysts  
 
The photocatalytic performance of ZnO nanoparticles of different sizes in the 
abatement of tetracycline and ibuprofen from water have been investigated in detail. 
The influence of different reaction factors like: different substrate concentrations and 
corresponding cat-to-sub ratios, pH values and formation of TC and IBP by-products 
during the course of treatment have been investigated. The possibility of the re-use of 
the photocatalyst (re-use experiments) has been checked. The contributions of 
adsorption over ZnO nanoparticles (in the dark) have been also checked in case of low 
concentrated (ppb range) and at high concentrated (ppm scale) TC and IBP solutions. 
The smaller, ca. 15-30 nm, sized ZnOe particles were prepared from ethanolic 
solution. The larger, ca. 100 nm, sized ZnOw particles were obtained from aqueous 
solution. 
 
Photocatalytic activity 
Photocatalytic abatement of ibuprofen was carried out over two types ZnO 
nanoparticles (Fig. 50 and 51). As is observed in Figure 50, the better abatement data 
are obtained in case of smaller (ca. 15-30 nm) ZnOe nanoparticles. With increasing 
the cat-to-sub ratios from 1 to 4, the photocatalytic abatement of ibuprofen proceeds 
faster and more effective and reaches (after 180 min of reaction) ca. 72, 51 and 31 %, 
at 10, 20 and 40 mg/L of photocatalysts, respectively.  
 
Figure 50. Photocatalytic abatement of ibuprofen in aqueous solution over ZnOe photocatalyst under 
UV-Vis irradiation; IBP conc.: 10 ppm, cat conc.: 10, 20 and 40 mg/L. 
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In case of larger crystals ZnOw the abatement is lower (Fig. 51) with ca. 19 % at a cat-
to-sub ratio of 1:1 compared to ZnOe. The ZnOw shows a lower onset activity in the 
abatement. The abatement increases significantly to finally ca. 68 % with the 
increased photocatalyst amount (cat-to-sub ratio of 1 to 4). Even the specific surface 
area of ZnOw is ca. 5 times lower than that of ZnOe, the observed abatements are only 
somewhat lower.   
 
Figure 51. Photocatalytic abatement of ibuprofen in aqueous solution over ZnOw photocatalyst under 
UV-Vis irradiation; IBP conc.: 10 ppm, cat conc.: 10, 20 and 40 mg/L. 
 
Additionally, the contribution of the adsorption of ibuprofen over ZnO nanoparticles 
has been checked in detail (Fig. 52). This experiment strongly confirms high 
contribution of adsorption to the abatement. Ca. 15 and 11% of IBP are adsorbed after 
60 min of contact time.  
 
 
Figure 52. Adsorption of ibuprofen in aqueous solution over ZnOe and ZnOw photocatalysts in the 
dark; IBP conc.: 10 ppm, cat conc.: 40 mg/L.  
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Again, adsorption is high for both photocatalysts. It is very likely that the higher onset 
activity of ZnOe is related to the higher adsorption of IBP compared to ZnOw. Finally, 
the observed abatements and the effective mean first reaction rates (Tab. 10) are 
slightly lower with the larger ZnOw nanoparticles compared to the smaller sized ZnOe.   
 
Table 10. Data of the abatement of ibuprofen (10 ppm) in aqueous solution during photocatalytic 
treatment over ZnOe (top) and ZnOw (bottom) at cat conc.: 10, 20 and 40 mg/L. Relative and absolute 
abatements (A) and corresponding experimental effective mean first order reaction rates (r) calculated 
after 30, 120 and 180 min of treatment. 
ZnOe 
irradiation 
time of IBP 
[min] 
rel. A 
[%] 
abs. A 
[mg/L] 
r 
[min -1] 
rel. A 
[%] 
abs. A 
[mg/L] 
r 
[min -1] 
rel. A 
[%] 
abs. A 
[mg/L] 
r 
[min -1] 
10 mg/L 20 mg/L 40 mg/L 
5 3.3 0.33 0.0066 4.9 0.49 0.0049 5.5 0.55 0.0028 
30 10.9 1.09 0.0036 23.4 2.34 0.0039 27.7 2.77 0.0023 
120 20 2 0.0017 37 3.7 0.0015 58 5.8 0.0012 
180 31.1 3.11 0.0017 50.5 5.05 0.0014 71.6 7.16 0.0010 
ZnOw 
irradiation 
time of IBP 
[min] 
rel. A 
[%] 
abs. A 
[mg/L] 
r 
[min -1] 
rel. A 
[%] 
abs. A 
[mg/L] 
r 
[min -1] 
rel. A 
[%] 
abs. A 
[mg/L] 
r 
[min -1] 
10 mg/L 20 mg/L 40 mg/L 
5 5.5 0.55 0.0110 4.2 0.42 0.0042 6.3 0.63 0.0032 
30 5.5 0.55 0.0018 9.4 0.94 0.0016 18.7 1.87 0.0016 
120 11.1 1.11 0.0009 20 2 0.0008 45 4.5 0.0009 
180 19.4 1.94 0.0011 27 2.7 0.0007 60 6 0.0008 
 
Additionally, the photocatalytic abatement of tetracycline over the ZnO 
photocatalysts has been studied using different amounts of the ZnO nanoparticles (10, 
20 and 40 mg/L) at a constant TC concentration of 10 ppm (Fig. 53).  
 
 
Figure 53. Photocatalytic abatement of tetracycline in aqueous solution over ZnOe photocatalyst under 
UV-Vis irradiation; TC conc.: 10 ppm, cat conc.: 10, 20 and 40 mg/L. 
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The photocatalytic behaviour of the TC abatement is similar to that of IBP. Ca. 74 and 
55 % of TC has been removed from solution after 180 min using 40 and 10 mg/L of 
photocatalyst, respectively (Tab. 11).  
 
Table 11. Data of the abatement of tetracycline (10 ppm) in aqueous solution during photocatalytic 
treatment over ZnOe (top) and ZnOw (bottom) at cat conc.: 10, 20 and 40 mg/L. Absolute abatement (A) 
and corresponding experimental effective mean first order reaction rates (r) calculated after 30, 120 and 
180 min of treatment. 
ZnOe 
irradiation 
time of TC 
[min] 
rel. A 
[%] 
abs. A 
[mg/L] 
r 
[min -1] 
rel. A 
[%] 
abs. A 
[mg/L] 
r 
[min -1] 
rel. A 
[%] 
abs. A 
[mg/L] 
r 
[min -1] 
10 mg/L 20 mg/L 40 mg/L 
5 1.6 0.16 0.0032 1.6 0.16 0.0016 6.5 0.65 0.0033 
30 22 2.2 0.0073 38.6 3.86 0.0064 45 4.5 0.0038 
120 41 4.1 0.0034 53 5.3 0.0022 64 6.4 0.0013 
180 55 5.5 0.0031 65 6.5 0.0018 73.9 7.39 0.0010 
ZnOw 
irradiation 
time of TC 
[min] 
rel. A 
[%] 
abs. A 
[mg/L] 
r 
[min -1] 
rel. A 
[%] 
abs. A 
[mg/L] 
r 
[min -1] 
rel. A 
[%] 
abs. A 
[mg/L] 
r 
[min -1] 
10 mg/L 20 mg/L 40 mg/L  
5 0.9 0.09 0.0018 1.1 0.11 0.0011 6.04 0.604 0.0030 
30 15 1.5 0.0050 22 2.2 0.0037 26 2.6 0.0022 
120 35 3.5 0.0030 39.9 3.99 0.0017 57.9 5.79 0.0012 
180 50 5 0.0028 57 5.7 0.0016 64.7 6.47 0.0008 
 
However, ZnOe shows a comparatively high onset activity in the first 10 min of 
reaction, followed by a continuous abatement in the second step, between 30 and 180 
min of photocatalytic treatment. With increasing photocatalyst amount, the abatement 
also increases. 
 
 
Figure 54. Photocatalytic abatement of tetracycline in aqueous solution over ZnOw photocatalyst under 
UV-Vis irradiation; TC conc.: 10 ppm, cat conc.: 10, 20 and 40 mg/L. 
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The photocatalytic abatment of TC over ZnOw nanoparticles and corresponding 
effective mean first order reaction rates are only slightly lower. However, ZnOw 
shows no distinct increase in the onset activity (Fig. 54).  
 
 
Figure 55. Adsorption of tetracycline in aqueous solution over ZnOe and ZnOw photocatalysts in the 
dark; TC conc.: 10 ppm, cat conc.: 40 mg/L.  
 
The adsorption of TC on the photocatalyst surface is high and reaches ca. 12 and 19 
% after 60 min (Fig. 55). The loadings of tetracycline over ZnO are higher than that 
found with IBP (Fig. 52), reflecting the different structure and molecular weight of the 
molecules.   
In order to differentiate between the photocatalytic performance of small and large 
sized ZnO nanoparticles, the influence of the concentration of ibuprofen and 
tetracycline on the course of abatement has been tested. The IBP and TC 
concentrations were increased from 5 and 60 ppm at constant photocatalyst content of 
10 mg/L. The results are summarized in Table 12.  
The course of photocatalytic abatement of ibuprofen over ZnOe, the more active 
photocatalyst, is shown in Figure 56. With increasing substrate concentration, the 
relative abatement decreases, however the absolute abatement is enhanced from 2.95 
to 14.4 mg/L. Remarkably, the abatement nearly continuously increases with time, 
indicating stable operation of the catalyst.  
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At low substrate concentration of 5 ppm and photocatalyst in excess by mass, at cat-
to-sub ratio of 2:1, the onset abatement is increased (Fig. 56). It is larger with ZnOe 
compared to ZnOw and larger for TC than for IBP.     
 
Table 12. Influence of the drug concentration on the relative (Rel.%) and absolute abatement (A) of 
tetracycline and ibuprofen over zinc oxide photocatalysts: ZnOe (top) and ZnOw (bottom) and the 
apparent photocatalytic reaction rate [mgsub/mgcat x min
-1] derived from the second stage of the course 
of abatement between 60 and 180 min; catalyst conc.: 10 mg/L. 
ZnOe 
Conc. of 
drug 
[ppm] 
rel. abatements [%] abatements 
reaction 
rates 
initial after 10 min 180 min 
between 
60 to180 min 
2nd stage 
10 
min 
60 
min 
180 
min 
A [mg/L] A [mg/L] Rel.[%] A [mg/L] min-1 
IBP 
5 7 36 59 0.35 2.95 23 1.25 0.0104 
10 7 18 41 0.7 4.1 23 2.3 0.0192 
20 5 17 33 1.0 6.6 16 3.2 0.0267 
40 4 14 26 1.6 10.4 12 4.8 0.04 
60 1 13 24 0.6 14.4 11 6.6 0.055 
TC 
5 38 50 75 1.9 3.75 25 1.25 0.0104 
10 17 44 65 1.7 6.5 21 2.1 0.0175 
20 12 23 42 2.6 8.4 19 3.8 0.0317 
40 8 5 15 3.2 6 10 4 0.0333 
60 5 4 11.5 3 6.9 7.5 4.5 0.0375 
ZnOw 
Conc. of 
drug 
[ppm] 
rel. abatements [%] abatements 
reaction 
rates 
initial after 10 min 180 min 
between 
60 to180 min 
2nd stage 
10 
min 
60 
min 
180 
min 
A [mg/L] A [mg/L] Rel.[%] A [mg/L] min-1 
IBP 
5 13 32 36 0.65 1.8 4 0.2 0.002 
10 5 17 27 0.5 2.7 10 1 0.008 
20 5 17 25 1 5 8 1.6 0.013 
40 5 14 21 2 8.4 7 2.8 0.023 
60 3 10 14 1.8 8.4 4 2.4 0.02 
TC 
5 25 39 65 1.25 3.25 26 1.3 0.0108 
10 6 33 55 0.6 5.5 22 2.2 0.0183 
20 4 21 38 0.8 7.6 17 3.4 0.0283 
40 1.2 2 12 0.48 4.8 10 4 0.033 
60 0.3 2 3 0.18 1.8 1 0.6 0.005 
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Figure 56. Photocatalytic abatement of ibuprofen in aqueous solution over smaller ca. 15-30 nm ZnOe 
crystals under UV-Vis irradiation; IBP conc.: 5, 10, 20, 40 and 60 ppm, ZnO conc.: 10 mg/L. 
 
Generally, the found abatement is higher with ZnOe than with ZnOw nanoparticles. 
E.g. ca. 24 % of 60 ppm concentrated IBP solution is converted over ZnOe compared 
to ca. 14 % over ZnOw after 180 min of treatment. It is observed that the abatement of 
IPB is markedly larger than that of TC, with ca. 11 and 3 %, respectively, under 
before mentioned conditions. ZnOw undergoes severe deactivation especially at higher 
substrate concentration, i.e. at low cat-to-sub ratio. With ZnOw photocatalyst, the 
absolute abatement is markedly decreased from 7.6 to 1.8 mg/L, with growing the TC 
concentration from 20 to 60 ppm. Whereas with ZnOe only a slightly decrease from 
8.4 to 6.9 mg/L is observed. This decrease is also reflected in the reaction rates (Tab. 
12). With increased substrate concentration, larger nanocrystals (ZnOw) are faster 
deactivated, compared to smaller ZnOe ones. This might be due to lower specific 
surface area of ZnOw.    
The photocatalytic abatement of TC has been also studied at very low concentration 
of 200 ppb, similar to that of the new emerging pollutants, at low photocatalyst 
amount of 0.5 mg/L (Fig. 57). It is characterized by an increase of abatement after 
short treatment time (5 min). Then, it is followed by a nearly continuous increase of 
the abatement curves. Ca. > 90 % of TC is abated after 180 min. ZnOe and ZnOw 
behaves similar. The adsorption measurements show a high affinity of the ZnO 
towards TC. At very low substrate concentration. Ca. 15 % of TC is adsorbed on 0.5 
mg photocatalyst (Fig. 58).  
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Obviously, the adsorption contributes to the initial abatement in the first 5 min, which 
amounts to ca. 32 and 18 % over ZnOe and ZnOw, respectively. The results show that 
nanosized zinc oxide is an effective catalyst for the depollution of TC in low 
contaminated water.   
 
 
Figure 57. Photocatalytic abatement of tetracycline in aqueous solution over ZnOe and ZnOw 
photocatalysts under UV-Vis irradiation; TC conc.: 200 ppb, cat conc.: 0.5 mg/L, cat-to-sub ratio of 
2.5.  
 
 
Figure 58. Adsorption of tetracycline in aqueous solution over ZnOe and ZnOw photocatalysts in the 
dark; TC conc.: 200 ppb, cat conc.: 0.5 mg/L, cat-to-sub ratio of 2.5.  
 
The adsorption behaviour at low and high TC concentrations, but similar cat-to-sub 
ratio, has been compared (Tab. 13). 
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Table 13. Data of the adsorption TC at low (top) and high (bottom) concentration over ZnOe and ZnOw 
(cat conc.: 0.5 (top) and 10 mg/L (bottom)). Relative and absolute adsorption (A) and corresponding 
specific loadings calculated after 30, 60, 120 and 180 min of adsorption; cat-to-sub ratios of 2.5 (top) 
and 2 (bottom). 
Adsorption of TC at low concentration (200 ppb) 
adsorption 
time of TC 
[min] 
rel. A 
[%] 
abs. A 
[mg/L] 
loading 
[mg/mg] 
rel. A 
[%] 
abs. A 
[mg/L] 
loading 
[mg/mg] 
ZnOe ZnOw 
30 20 0.040 0.080 7.5 0.015 0.030 
60 35.5 0.071 0.142 26.5 0.053 0.106 
120 28.5 0.057 0.114 23.5 0.047 0.094 
180 26.5 0.053 0.106 20 0.040 0.080 
Adsorption of TC at high concentration (5 ppm) 
adsorption 
time of TC 
[min] 
rel. A 
[%] 
abs. A 
[mg/L] 
loading 
[mg/mg] 
rel. A 
[%] 
abs. A 
[mg/L] 
loading 
[mg/mg] 
ZnOe ZnOw 
30 5.6 0.28 0.0280 4 0.200 0.020 
60 9.6 0.48 0.0480 3.9 0.195 0.016 
120 3.4 0.17 0.0170 2.3 0.115 0.012 
 
It is surprisingly found that the specific TC loading [mgTC/mgcat] on the photocatalysts 
is markedly enhanced at very low (200 ppb) compared to higher (5 ppm) 
concentration. The inspection at higher concentration shows that this effect of 
enhanced adsorption in low concentrated solution, but at similar cat-to-sub ratio, starts 
already below 10 ppm (Fig. 59).  
 
 
Figure 59. The ZnO photocatalysts loading [mgsub/mgcat] of tetracycline and ibuprofen in the aqueous 
solution at high substrate concentration. Conditions of measurements: adsorption time: 5 min; ZnO 
conc.: 10 mg/L. 
 
The specific loading changes (increase and decrease) with contact time probably due 
to changes of the surface (hydration). At low concentration and low photocatalyst 
amount, the loading further increases markedly with growing TC concentration (Fig. 
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60 inset). But the effect of higher loading at low substrate and catalyst concentration 
is maintained, with prolonged contact time (Tab. 13).  
 
 
Figure 60. The ZnO photocatalysts loading [mgsub/mgcat] of tetracycline and ibuprofen in the aqueous 
solution at high and low (inset) substrate concentrations. Conditions of measurements: adsorption time: 
5 min; ZnO content: 10 mg/L at high, and 0.5 mg/L at low concentrations; asterisk (*) indicates the cat-
to-sub ratio of 1. 
 
The high TC loading per milligram of ZnO photocatalyst, at low concentrated 
solution, is also observed with titania (compare Chapter 3.3).  
 
 
 
Figure 61. Schematic representation of micelles, hemimicelle and admicelle formation; depending on 
the arrangement of molecules.[197] 
 
Own estimations show that these loadings exceed the monolayer adsorption capacity 
of ca. 0.011 and 0.002 mgTC/mgcat for ZnOe and ZnOw, respectively. They require 
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multilayer adsorption as can be realized with aligned adsorbed molecules (Langmuir 
Blodgett - type) and admicelles formation with amphiphilic molecules and solid 
particles as well as their aggregation binding high amounts of substrate (Fig. 61).  The 
large crystal faces of the ZnOw favour the formation of mono- and multilayer (Fig. 
62). 
 
 
Figure 62. Schematic representation of the adsorption of tetracycline on zinc oxide nanoparticles a) 
multilayer adsorption on large size ZnOw crystals, b) monolayer adsorption on small size ZnOe crystals. 
 
In contrast, at higher (ppm range) TC concentration, the formation micelles in 
solution competes with the adsorption on the particles rendering the formation of 
multilayers or admicelles more difficult.   
 
Influence of pH solution 
The influence of the pH value (varied between 3 and 9) has been studied during 
photocatalytic abatement of ibuprofen and tetracycline. 
 The activity of the ZnO photocatalysts under acidic, neutral and alkaline reaction 
conditions has been tested at the cat-to-sub ratio of 2, using 20 mg/L of photocatalyst 
and 10 ppm of drug (Fig. 63-66).  
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Figure 63. Influence of pH value of the reaction solution on the photocatalytic abatement of ibuprofen 
in aqueous solution over ZnOe photocatalyst under UV-Vis irradiation; IBP conc.: 10 ppm, cat conc.: 
20 mg/L. 
 
The photocatalytic abatement of ibuprofen over ZnOe and ZnOw is strongly 
influences by pH of solution (Fig. 63 and 64). The abatement of IBP is markedly 
dropped under acidic conditions (pH=3). The lower activity of the zinc oxide can be 
explained by the increased electrostatic repulsion between the protonated surface of 
the ZnO nanoparticles and the substrate molecules. After 180 min of treatment, only 
ca. 8 and 5 % of IBP is abated in the acidic conditions over ZnOe and ZnOw 
nanoparticles, respectively. 
 
 
Figure 64. Influence of pH value of the reaction solution on the photocatalytic abatement of ibuprofen 
in aqueous solution over ZnOw photocatalyst under UV-Vis irradiation; IBP conc.: 10 ppm, cat conc.: 
20 mg/L. 
 
The influence of pH value on the photocatalytic abatement of tetracycline over ZnOe 
and ZnOw has been also investigated (Fig. 65 and 66). The abatement is markedly 
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decreased over both ZnO type catalysts under acidic conditions due to the improved 
electrostatic repulsion between the positively charged TC (ab+c species, compare A 
1.2 Fig. 29) and the positive charged catalyst surface in aqueous solution (Pzc of ZnO 
is ca. 9[198,199]).  Enhanced degradation of TC is observed under alkaline conditions 
(Fig. 65 and 66). This is due to improved interaction of the hydroxylated photocatalyst 
surface and negatively charged TC (deprotonated -OH groups) by strong hydrogen 
bonding (Scheme 4). The enhancement of the pH value from 7 to 9 leads finally to an 
increase of the photocatalytic abatement of tetracycline from ca. 65 to 90 % over 
ZnOe and from ca. 50 to 85 % over ZnOw, respectively. 
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Scheme 4. Schematic representation of the interactions between ZnO hydroxylated surface and 
tetracycline molecule at acidic and alkaline solutions. 
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Figure 65. Influence of pH value of the reaction solution on the photocatalytic abatement of 
tetracycline in aqueous solution over ZnOe photocatalyst under UV-Vis irradiation; TC conc.: 10 ppm, 
cat conc.: 20 mg/L. 
 
 
 
Figure 66. Influence of pH value of the reaction solution on the photocatalytic abatement of 
tetracycline in aqueous solution over ZnOw photocatalyst under UV-Vis irradiation; TC conc.: 10 ppm, 
cat conc.: 20 mg/L. 
 
Therefore, also the adsorption of IBP and TC is increased at pH=9 and markedly 
decreased at low pH=3 (Fig. 67). This finding shows the close relation between the 
adsorption and the photocatalytic abatement properties observed with the ZnO 
nanoparticle photocatalysts. The adsorption of TC on the ZnO is higher than that of 
IBP due to amphiphilic, zwitterionic nature and the higher polarity (polar substituents) 
of tetracycline compared to ibuprofen, which possess only one -COOH polar group 
(compare A 1.2, Fig. 28).  
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These special TC properties improve the polar interactions with the photocatalyst 
surface. The adsorption on the photocatalyst surface increases with contact time due 
to increased surface hydroxylation. 
  
Figure 67. Influence of the pH value on the adsorption of tetracycline (left) and ibuprofen (right) in 
aqueous solution over ZnOe and ZnOw. TC and IBP conc.: 10 ppm, cat conc.: 20 mg/L, cat-to-sub ratio 
of 2. 
 
Formation of ibuprofen and tetracycline intermediates 
The formation of reaction intermediates of ibuprofen and tetracycline during the 
course of photocatalytic treatment over the two different sized ZnO nanoparticles 
have been followed by ESI-TOF-MS measurements. The ESI-TOF-MS spectra of 
starting IBP and TC solution have been explained before (compare A 1.2, Fig. 35 and 
33). The molecular peaks [M-H]- of IBP and TC formed in the negative ionization 
mode appear at m/z  205 and 443, respectively.  
 
The photocatalytic abatement of ibuprofen under UV-Vis irradiation over smaller 
and larger ZnO crystals is accompanied by the formation of reaction intermediates 
(Fig. 68). After 30 min of treatment a lot of IBP intermediates with different masses 
formed over ZnOe appear in the solution (Fig. 68 a). With prolonged time (240 min) 
the majority of high intensity molecular peaks appear in the m/z range between 90 and 
350. They are probably related to the formation of the benzene derivates (one ring 
aromatics) and deeper oxidation intermediates (e.g. ring opening, aliphatic acids).  
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The magnification of this range shows a special pattern of peak distribution. It 
consists of distinguished intermitting single groups of m/z peaks which differ by ca. 
20 m/z. Besides a couple of low intensity peaks appear in the m/z range between 400 -
550, and around 661 and higher. Besides, some IBP aggregates are shown at m/z 273, 
443, 501, 661 and 889 (also present in the starting IBP solution, compare A 1.2, Fig. 
34). The abatement of IBP over ZnO leads to the formation of a huge amount of 
different high molecular masses by-products. Based on ESI-TOF-MS spectra, the 
formation of IBP intermediates over the smaller and larger ZnOw nanoparticles looks 
similar (Fig. 68). However the IBP absorption bands (UV-Vis spectra, data not 
shown) monitored during the course of treatment differ in the intensity by 264 nm. 
The formation of ibuprofen by-product is higher with ZnOe than with ZnOw. This 
observation is in an agreement with the adsorption data (Fig. 52 and 59). The 
formation of intermediates increases steadily during the course of treatment up to 180 
min (Fig. 69). This finding related to the formation of IBP intermediates is different 
from that of titania (compare Chapter 3.1, Fig. 9). 
 
a) 
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b) 
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Figure 68. Negative ESI-TOF-MS spectra of the aqueous ibuprofen solution after photocatalytic 
treatment over (a) ZnOe after 30 (top) and 240 min (middle), including higher magnification of 
spectrum after 240 min (bottom); and over (b) ZnOw after 30 (top) and 240 min (middle), including 
higher magnification of spectrum after 240 min (bottom). Reaction conditions: UV-VIS irradiation, 
IBP conc.: 20 ppm, cat conc.: 20 mg/L; cat-to-sub ratio of 1. 
 
 
Figure 69. Formation of the temporary intermediates of ibuprofen in aqueous solution during 
photocatalytic treatment over ZnO photocatalyst based on UV-Vis absorbance at λmax 262 nm; IBP 
conc.: 20 ppm, cat conc.: 20 mg/L.  
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Additionally, the formation of tetracycline intermediates has been checked during the 
course of photocatalytic abatement (Fig. 70). The ESI-TOF-MS spectra of TC by-
products show also typically peak group pattern by location and intensity. Three 
groups of peaks arise around m/z 100, 136 and 170 and lower intense peaks around. 
m/z 250 and 350 and higher. This pattern is not changed with treatment.  
In detail after 30 min of UV-Vis irradiation higher mass peaks are formed. Peaks m/z 
at 579, 501, and 465 are higher than mass of TC (m/z 443). These peaks probably 
belong to partial oxidised by-products enhancing the molecular mass by oxygen 
insertion (Scheme 5).  
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Scheme 5. The proposed degradation pathway of tetracycline; arrow indicates degradation by oxidant 
agent like ozone or hydroxyl radicals.[200] 
 
The intensity of these peaks slight decreases during prolonged abatement. After 240 
min formation of some intermediates gives rise at m/z peaks below m/z < 400. The 
main intense signals located between m/z 100 and 200, mainly around m/z 102, 133 
and 170, likely belong to decomposition products, especially related to anthraquinone, 
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quinone derivates, benzoic acid derivates, substituted benzene and phenol derivates 
which are further decomposed to aliphatic acids, alcohols and ethers with lower than 
100 m/z (compare Chapter 3.2). Higher m/z peaks at 180, 188, 265 and 354 also 
appear. These peaks are new and differ from that found with titania. They can be 
assigned to by-products containing three or two 6-membered aliphatic or aromatic 
rings. It is observed that the photocatalytic abatement of TC over both ZnO 
photocatalysts is very similar (Fig. 70 a and b). Number and amount of by-products of 
TC is reduced, compared to IBP. 
 
a) 
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b) 
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Figure 70. Negative ESI-TOF-MS spectra of the aqueous tetracycline solution after photocatalytic 
treatment over (a) ZnOe after 30 (top) and 240 min (middle), including higher magnification of 
spectrum after 240 min (bottom); and over (b) ZnOw after 30 (top) and 240 min (middle), including 
higher magnification of spectrum after 240 min (bottom). Reaction conditions: UV-VIS irradiation, TC 
conc.: 20 ppm, cat conc.: 20 mg/L; cat-to-sub ratio of 1. 
 
Re-use experiments 
The re-usability of ZnO nanoparticles has been checked by cycling (re-use) 
experiments during photocatalytic abatement of ibuprofen and tetracycline. These 
experiments were carried using 10 mg/L of ZnO photocatalysts and a drug 
concentration of 10 ppm; i.e. at equal cat-to-sub ratio of 1.  
 
 
 
Figure 71. Photocatalytic abatement of ibuprofen in aqueous solution over ZnOe photocatalyst under 
UV-Vis irradiation after 3 runs of treatment; IBP conc.: 10 ppm, cat conc.: 10 mg/L. 
 
The photocatalytic abatement of ibuprofen over smaller ZnOe and larger ZnOw 
nanoparticles in three runs of treatment is shown in Figures 71 and 72. The abatement 
of ibuprofen over smaller ZnOe nanoparticles decreased from ca. 26, 22 to 14 % after 
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first, second and third run, after 180 min of treatment, respectively (Fig. 71). The 
somewhat lower photocatalyst activity is observed with larger ZnO nanoparticles (Fig. 
72). Ca. 18, 12 and 7 % is abated over ZnOw photocatalyst after 3 runs of treatment at 
the same time. Ca. 50 % loss of activity in the IBP abatement after 3rd run is observed 
for both ZnO photocatalysts. 
 
 
Figure 72. Photocatalytic abatement of ibuprofen in aqueous solution over ZnOw photocatalyst under 
UV-Vis irradiation after 3 runs of treatment; IBP conc.: 10 ppm, cat conc.: 10 mg/L. 
 
Additionally, re-use experiments over ZnO nanoparticles during photocatalytic 
abatement of tetracycline are shown in Figures 73 and 74. Again, the smaller 
nanoparticles show higher abatement of tetracycline and ca. 69, 58 and 31 % of TC is 
removed from the solution, after 180 min of each run, respectively (Fig. 73). Lower 
abatement is obtained with larger ZnOw crystals, where ca. 57, 32 and 29 % of TC is 
removed from the solution after 1st, 2nd and 3rd run, respectively (Fig. 74). Finally, ca. 
50 % loss of activity of TC is observed after the 3rd run over smaller and larger ZnO 
crystals, which is similar to IBP. 
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Figure 73. Photocatalytic abatement of tetracycline in aqueous solution over ZnOe photocatalyst under 
UV-Vis irradiation after 3 runs of treatment; TC conc.: 10 ppm, cat conc.: 10 mg/L. 
 
 
Figure 74. Photocatalytic abatement of tetracycline in aqueous solution over ZnOw photocatalyst under 
UV-Vis irradiation after 3 runs of treatment; TC conc.: 10 ppm, cat conc.: 10 mg/L. 
 
The experimental findings of the re-use experiments are in line with former presented 
photocatalytic results which show higher conversion of TC compared to IBP over 
ZnO and but larger formation of by-products with IBP over larger ZnOw particles. 
The activity of re-used catalysts decrease in the order:  
 
ZnOe TC > ZnOw TC > ZnOe IBP > ZnOw IBP; 
 
whereas the relative decrease in activity after the 3rd run is about 50 % and similar for 
all the ZnO photocatalysts - drug combinations.      
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Summary 
 The influence of particle size and texture effect of two nanosized ZnO 
photocatalyts on the abatement of ibuprofen and tetracycline has been 
investigated. 
 The activity of larger (ZnOw) nanoparticles is somewhat lower than that of 
smaller (ZnOe) one. Even the larger ZnOw nanoparticles have ca. 5 times 
lower adsorption capacity than ZnOe, the photocatalytic activity is still high. 
Ca. 50 and 27 % of IBP and 65 and 57 % of TC have been effectively abated 
from solution (cat-to-sub ratio of 2, 180 min of treatment, 60 W of lamps) over 
ZnOe and ZnOw, respectively.  
 High onset activity (first 10 min) of ZnOe is due to high adsorption (influence 
of nanoporosity), whereas initial activity observed with ZnOw is lower because 
of lower adsorption. 
 It is observed that adsorption of TC and catalysts loadings are higher at low 
ppb range. Again, the self-agglomeration of TC molecule close to catalyst 
surface facilitates the high adsorption. Additionally, calculation showed that 
the surface coverage of TC at low concentration requires the multilayer 
adsorption formation for ZnOw (with monolayer adsorption of ca. 0.002 
mgTC/mgcat) and monolayer adsorption formation for ZnOe (ca. 0.011 
mgTC/mgcat). 
 Both ZnO sized nanoparticles shows similar properties during formation of 
IBP and TC intermediates. However, the formation of IBP intermediates is 
somewhat higher for smaller ZnOe crystals. A broaden range of peaks 
distribution (with masses between 90 - 350 and 400 - 550) appears on the 
ZnOe surface. This might be due to high specific loading (adsorption) of IBP 
on ZnOe.  Formation of TC intermediates is similar for both ZnO. 
Photocatalytic abatement of tetracycline is slightly higher than that of 
ibuprofen. This is also confirmed by different type of intermediates formation. 
The formation of TC intermediates with higher mass >200 (aromatic and 
cyclic aliphatic rings) is observed, but the number of TC intermediates is 
reduced compared to IBP. 
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3.5. Final conclusions 
 
 Besides commercial TiO2 (P25, Degussa), novel titania (doped titania, titania 
nanotubes, titania/MOF composites, and T-MOF-125) and two different sized 
nanoparticulate zinc oxide based photocatalysts have been prepared, 
characterized and tested in the photocatatalytical decomposition of two 
pharmaceuticals ibuprofen (IBP) and tetracycline (TC). 
 These materials differ in the texture, morphology and specific surface area and 
were characterized by the XRD, TEM and N2 adsorption-desorption 
measurements.  
 Photocatalytic performances have been tested under more reliable 
photocatalytic conditions; at low cat-to-sub ratio, at low photocatalyst and 
substrate concentrations, and at low irradiation intensity (sun light). These 
severe conditions are usually not considered in the literature. 
 
IBP and TC at ppm range 
 The photocatalytic abatement of IBP and TC at low ppm range (5 - 60 ppm of 
substrate) was carried out over titania, titania doped photocatalysts and zinc 
oxide nanoparticles (Tab. 15 ).  
 The formation of IBP and TC intermediates has been investigated by ESI-
TOF-MS measurements. Influence of pH on the degradation, re-use of 
catalysts and its adsorption behaviours have been also tested during the course 
of abatement. 
 The samples show still high photocatalytic activity (abatement/degradation of 
pharmaceuticals) even most severe conditions which have been applied. 
 Titania shows the highest activity which is assigned to very reactive species 
like electron holes (h+) and titania redox pairs (Ti3+/Ti4+), whereas ZnO is less 
active, but is known to be an efficient in the formation of reactive •OH 
radicals. The oxidation potential of hydroxyl radicals is lower than for h+. 
 The doping of titania does not increased the photocatalytic efficiency. It leads 
to decrease of the onset activity, compared to titania. Over all, the abatement 
achieved with the phocatalysts decreases in the order:  
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TiO2 > Zr-TiO2 >* ZnOe > ZnOw 
 
(*) with exception in TC abatement, where ZnOe > Zr-TiO2. 
 
 The adsorption of IBP and TC on ZnO nanoparticles is higher than on titania. 
The enrichment by adsorption contributes to the comparatively high 
photocatalytic performance of ZnO nanoparticles. 
 Over titania a lot of intermediates are formed, but they are decomposed during 
the course of photocatalytic treatment. Doping of titania with zirconium 
reduces the formation of intermediates, however, they are not decomposed and 
block the catalyst surface. Poisoning of the catalyst makes the re-use more 
difficult. 
 Over ZnO the formation of by-product increases. It is assigned to the 
significantly enhanced specific loading (adsorption) of pharmaceuticals on 
ZnO surface compared to titania, which facilities the formation of partial 
oxidation by-products nearby the surface of the catalyst (Tab. 14 ). 
 
TC at ppb range 
 Decomposition of tetracycline at ppb range has been studied with titania, 
doped titania and porous titania based materials (titania nanotubes (TNs), 
Ti/MIL composites and porous MIL-125 materials). At low catalyst 
concentration and at low cat-to-sub ratio of ca. 2, all samples show high 
activities in the TC abatement. 
 The very high adsorption of samples, contributes significantly to the TC 
abatement (40 - 65  %). All materials behave also photocatalytic and degrade 
the TC. With titania nearly 100 % of abatement is observed after 90 min of 
treatment. 
 The photocatalytic abatement decrease in the order: 
 
titania (ca. 100 % ) > TNs  (ca. 90 %) >  
MIL-125 (ca. 80 %) > Ti/MIL-101 (ca. 64 %) 
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 At very low substrate concentration unexpected increase of the adsorption 
(specific TC loading) on the catalysts surface is observed. This high TC 
adsorption at low concentration is explained by multilayer or admicelle 
formation by amphiphilic TC molecules. At high concentration (ppm) range, 
formation of self-aggregates and admicelles in the solution compete with (and 
decrease) the adsorption on the photocatalyst.  
Therefore, the photocatalytic abatement behavior at low (ppb) concentration 
is different from high (ppm) concentration. 
 The results show that the photocatalysis is of high potential. It can be 
successfully used for the photocatalytic remediation of water from very low 
concentrated emerging pharmaceutical pollutants. 
 
Table 14. Data of the photocatalytic abatement of ibuprofen and tetracycline (10 ppm) in water during 
photocatalytic treatment over titania, Zr-TiO2 and ZnO photocatalysts (cat conc.: 10, 20 and 40 mg/L). 
Relative and abatements (A) and corresponding experimental effective mean first order reaction rates 
(r) calculated after two stages of reaction 0-5 and 60-180 min. 
Conc. of 
titania  
P25 
[mg/L] 
between 0-5 min between 60-180 min 
final  
abatement 
rel. A 
[%] 
abs. A 
[mg/L] 
r 
[min -1] 
rel. A 
[%] 
abs. A 
[mg/L] 
r 
[min -1] 
[%] 
Ibuprofen 
10 17 1.7 0.0340 22.7 2.27 0.0019 88 
20 27 2.7 0.0270 25.4 2.54 0.0011 97 
40 34 3.4 0.0170 13.2 1.32 0.0003 100 
 tetracycline  
10 11 1.1 0.0220 24.5 2.45 0.0020 74 
20 23 2.3 0.0230 29.8 2.98 0.0012 85 
40 22 2.2 0.0110 27.3 2.73 0.0006 96 
 
conc. of 
Zr-TiO2 
[mg/L] 
between 0-5 min between 60-180 min 
final  
abatement 
rel. A 
[%] 
abs. A 
[mg/L] 
r 
[min -1] 
rel. A 
[%] 
abs. A 
[mg/L] 
r 
[min -1] 
[%] 
ibuprofen 
10 5 0.5 0.0100 38 3.8 0.0032 56 
20 6 0.6 0.0060 40 4.0 0.0017 71 
40 11 1.1 0.0055 29 2.9 0.0006 89 
 tetracycline  
10 4 0.4 0.0080 20 2.0 0.0017 37 
20 5 0.5 0.0050 27 2.7 0.0011 55 
40 8 0.6 0.0030 30 3.0 0.0006 70 
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conc. of 
ZnOe 
[mg/L] 
between 0-5 min between 60-180 min 
final  
abatement 
rel. A 
[%] 
abs. A 
[mg/L] 
r 
[min -1] 
rel. A 
[%] 
abs. A 
[mg/L] 
r 
[min -1] 
[%] 
ibuprofen 
10 3.3 0.33 0.0066 21.7 2.17 0.0018 31 
20 4.9 0.49 0.0049 18.9 1.89 0.0008 50 
40 5.5 0.55 0.0028 32.2 3.22 0.0007 71 
 tetracycline  
10 1.6   0.16 0.0032 25 2.5 0.0021 55 
20 1.6 0.16 0.0016 19.6 1.96 0.0008 65 
40 6.5 0.65 0.0033 19.2 1.92 0.0004 74 
 
conc. of 
ZnOw 
[mg/L] 
between 0-5 min between 60-180 min 
final  
abatement 
rel. A 
[%] 
abs. A 
[mg/L] 
r 
[min -1] 
rel. A 
[%] 
abs. A 
[mg/L] 
r 
[min -1] 
[%] 
ibuprofen 
10 5.5 0.55 0.0110 11.1 1.11 0.0009 19 
20 4.2 0.42 0.0042 11.9 1.19 0.0005 27 
40 6.3 0.63 0.0032 35.6 3.56 0.0007 60 
 tetracycline  
10 0.9 0.09 0.0018 25 2.50 0.0021 50 
20 1.1 0.11 0.0011 25.3 2.53 0.0011 57 
40 6 0.60 0.0030 23.5 2.35 0.0005 64 
 
 
Table 15. Data of the relative absorption of ibuprofen and tetracycline (10 ppm) in water during 
photocatalytic treatment over titania, Zr-TiO2 and ZnO photocatalysts (cat conc.: 40 and 100 mg/L). 
Catalysts loading calculated after 30, 60 and 120 min. 
ibuprofen 
10 ppm of IBP 
100 mg/L of cat 
10 ppm of IBP 
40 mg/L of cat 
TiO2 Zr-TiO2 ZnOe ZnOw 
Time 
[min] 
rel. 
Ads 
[%] 
loading 
[mg/mg] 
rel. 
Ads 
[%] 
loading 
[mg/mg] 
rel. 
Ads 
[%] 
loading 
[mg/mg] 
rel. 
Ads 
[%] 
loading 
[mg/mg] 
30 1.4 0.0014 18 0.0180 12 0.0300 7 0.0175 
60 5 0.0050 19 0.0190 15 0.0375 11 0.0275 
120 4.3 0.0043 17 0.0170 16 0.0400 13 0.0325 
 
tetracycline 
10 ppm of TC 
40 mg/L of cat 
10 ppm of TC 
40 mg/L of cat 
TiO2 Zr-TiO2 ZnOe ZnOw 
Time 
[min] 
rel. 
Ads 
[%] 
loading 
[mg/mg] 
rel. 
Ads 
[%] 
loading 
[mg/mg] 
rel. 
Ads 
[%] 
loading 
[mg/mg] 
rel. 
Ads 
[%] 
loading 
[mg/mg] 
30 0 0 5 0.0125 16 0.0400 12 0.0300 
60 0 0 13 0.0325 21 0.0525 15 0.0375 
120 0 0 0 0 22 0.0550 16 0.0400 
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It is finally concluded (Tab. 16) that: 
1) Titania shows the best photocatalytic performance with very high final 
abetment.  
2) In tendency, higher IBP abatement over titania and lower over ZnO is 
observed. This is related to the different adsorption behaviors of these 
materials.  
Adsorption data show that titania has very low adsorption in the order:  
adsorption of IBP > adsorption of TC 
and ZnO has very high adsorption in the order: 
adsorption of TC >  adsorption of IBP. 
The high onset activity of titania is assign to the present of highly reactive 
electron holes species (of high oxidation power) and titania redox (Ti3+/Ti4+) 
pairs on the titania surface, compensating the lower adsorption and medium 
activity. Obviously, the deactivation is faster with titania, due to its high 
reactivity. 
 
3) The doping of titania markedly decrease the onset activity. The onset with Zr-
TiO2 is nearly diminished what leads to lower abatement. The photocatalytic 
activity is partially compensated by the improved adsorption and slowly 
catalyst deactivation (high reaction rates).  
4) Lower photocatalytic activity is observed with ZnO nanoparticles. However, 
ZnO photocatalyst is known in the literature as a material producing the 
hydroxyl radicals with high oxidation power. 
5) Comparison between photocatalysts shows that the best photocatalytic 
performances are achieved by the presence of high reactive oxidation species 
(with titania) or by high loading (with ZnOe).  
6) The detailed inspections of abatement (at cat-to-sub ration of 1) and adsorption 
data show that:  
ZnO has higher adsorption affinity toward drugs compared to titania based 
photocatalysts. Adsorption is maintained in the tendency: 
 
ZnO > TiO2 
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This compensates in part lower onset activity of ZnO (less reactive electron 
holes (h+) sites), but further medium abatement, which might be also attributed 
to higher •OH radicals productivity. 
Finally, titania posses highly reactive electron holes and high redox potential 
(due to presence of Ti3+/Ti4+ pairs) used for direct oxidation of organics, 
whereas ZnO has higher efficiency for hydroxyl radicals production. The final 
photocatalytic abatement can be summarized by order: 
TiO2 (h
+ - Ti3+/Ti4+ ) > ZnO (•OH) 
7) Porous materials like titania/MOF composites and titania nanotubes show very 
high adsorption, but low onset activity and medium abatement. The 
deactivation is slower what can be the main advantage for long-term use.   
 
Table 16. The final summary of the photocatalytic and adsorption properties of novel titania and ZnO 
photocatalysts in the water remediation. 
photocatalysts adsorption onset activity 
2nd stage 
activity 
final 
abatement 
deactivation 
titania very low very high medium very high fast 
Zr-TiO2 medium low high high slow 
ZnOe very high medium high medium medium 
ZnOw high low high low fast 
porous materials very high low low medium slow 
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Appendix 1: Experimental details 
 
A 1.1. Photocatalytic materials preparation and characterization 
The photocatalytic abatement of two model water pollutants, pharmaceuticals 
ibuprofen and tetracycline, have been investigated over different types of highly 
active photocatalytic materials. Titania doped materials as well as porous titania based 
photocatalysts and zinc oxides have been synthesised and supplied by co-workers of 
the Vietnamese Academy of Science and Technology in Hanoi in Vietnam (VAST) 
and of the King Abdulaziz City for Science and Technology (KACST), Riyadh, in 
Saudi Arabia. All followed photocatalytic materials have been characterized by XRD, 
N2 adsorption-desorption isotherms and TEM images.  
 
Titanium dioxide (TiO2) 
The titania TiO2 can exist in three different phases: anatase, rutile and brookite. These 
phases have the same fundamental structural octahedron unit (TiO6) but differ in the 
arrangement.[1] In anatase and rutile, the crystal structure consists of an oxygen 
octahedron frame. The basic building block consists of a titanium atom in the lattice 
surrounded octahedrally by six oxygen atoms and each oxygen atom is surrounded by 
three titanium atoms in trigonal arrangement (Fig. 1). Each octahedron in the rutile 
structure is surrounded by ten neighbouring octahedra (two sharing the edge of 
octahedron and eight sharing the corner of the octahedron). In the anatase structure, 
each octahedron is in contact with eight octahedra (four sharing the edge and four 
sharing the corner). The experimental lattice parameters: for anatase: a=b=3.7842 Å; 
c=9.5146 Å and for rutile: a=b=4.5937 Å; c=2.9581 Å.[2] Density of anatase: 3.84 and 
rutile: 4.26 g/cm3.[3] Brookite, which has an orthorhombic crystal structure, is usually 
found in minerals and has no practical importance due to its low stability (structure 
not shown).[4]  
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a) b)  
Figure 1. The main crystallographic forms for the TiO2 phases (left): a) anatase (tetragonal) and b) 
rutile (tetragonal); Ti (yellow); O (grey); and (right) octahedral structures of different TiO2 
polymorphs.[5] 
 
The fundamental differences of these two crystalline structures (anatase and rutile) 
will end up with different properties. They differ in optical properties, band gap 
values and carrier transport. Rutile, which is the most thermodynamically stable one, 
has the highest density and the most compact atomic structure.[6] While, anatase is a 
metastable phase and it shows superior photocatalytic performance because of fast 
carrier transport and less electron-hole pairs recombination. The energies of the band 
gaps of anatase and rutile are 3.2 eV (384 nm)[7,8] and 3.02 eV (411 nm),[9,10] 
respectively. It has been found that in many cases, the anatase phase is 
photocatalytically more active due to generation of highly energetic holes at the 
interface, which are strong oxidants. The metastable anatase transforms into the rutile 
phase irreversibly at the temperature of 700°C~1000°C. This transformation is 
determined by several factors including crystallite size and impurity levels.[11,12]  
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Figure 2. Apparatus for the flame pyrolysis process used for the synthesis of titania P25 (Degussa, 
Germany). 
 
The main process used in the industrial production of titania P25 is the flame 
pyrolysis process, also known as the Aerosil® process.[13] The overall reaction of the 
process is given in Equation 1. 
 
TiCl4 (g) + O2 (g) → TiO2 (g) + 2 Cl2 (g)    (1) 
 
The method was first employed by Degussa in 1942. The precursor is introduced into 
hydrogen-oxygen diffusion flame forming molecular or cluster compounds in the gas 
phase. The particle formation process in the flame pyrolysis is shown in Figure 2. As 
the aerosol stream leaves the hot temperature zone and cools down, particles are 
formed through homogeneous nucleation from supersaturated vapor. On the way to 
the collection zone, particles continuously grow through condensation, surface 
reactions, and coagulation and aggregation mechanisms. Post-processing like the 
calcination stage is performed before product collection due to chlorine gas absorption 
by titania. Finally, particles are collected in a bag house filter, electrostatic 
precipitator or cyclone separator. Serious operational problems can exist during 
transport: for example, the particles can be removed from the process stream by 
diffusion to the reactor walls.[14] The flame synthesis normally results in micron sized 
particles, thus careful control and post treatments are required to get nanoparticles. 
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The resulting titania P25 product is 99.5 % pure and has a composition ratio of 80 to 
20 of anatase to rutile.[15] 
The XRD patterns show the pure crystalline anatase and rutile compared with titania 
P25 (Fig. 3). The titania P25 sample consists of a mixture of anatase with a minor 
amount of rutile. 
 
 
Figure 3. XRD patterns of  rutile (a), titania P25 (b) and anatase (c).[16] 
  
The titania P25 sample consists of agglomerated, round shaped nanoparticles with an 
average size of 20 nm, confirmed by TEM and SEM images (Fig. 4). 
 
a)  b)  
Figure 4. TEM (a) and SEM (b) images of titania P25 photocatalyst. 
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Figure 5 shows the N2 adsorption - desorption isotherms of titania displayed 
adsorption - desorption isotherms characteristic of non - microporous materials with 
the presence of both meso- and macroporosity (uptake p/p0 > 0.8). The specific 
surface area amounts ca. 55 m2/g.[17] It contains a very low specific pore volume the 
pore size distribution showing a maximum at ca. 15 nm, probably corresponding to 
the inter - particle mesoporosity of particle agglomerates. This is consistent with other 
studies reporting 10 nm pore size mesopores with 200 - 215 nm size agglomerates.[18] 
 
 
Figure 5. The N2 adsorption - desorption isotherms of titania P25 (Degussa).
[19] 
 
Doped titania photocatalysts  
The zirconium (Zr), iron (Fe) and nitrogen (N) doped TiO2 materials have been 
prepared by sol-gel synthesis combined with hydrothermal treatment and finally 
treated by chemical vapour deposition (CVD) method. All doped titania materials 
have been provided by the Vietnamese Academy of Science and Technology in 
Hanoi, Vietnam. The powdered titania precursor, further used for modifications, has 
been prepared in the following way:  
A determined amount of TiCl4 was added drop wise into i-propanol. The resulting 
solution was introduced into distilled water in an ice-water bath with vigorously 
magnetic stirring. After that, the pH value of this acidic solution was adjusted to 7 by 
adding an aqueous ammonia solution to form a white gel. The resulting gel was aged 
for 24 h at room temperature under stirring condition. The obtained white precipitate 
was filtered and washed repeatedly with distilled water until complete removal of 
chloride ions.  
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Thereafter, the precipitate was well-dispersed by treating in an ultrasonic batch. Then, 
30 % H2O2 was added drop wise into this mixture under stirring. The resulting yellow 
transparent solution was poured into an autoclave and heated at 100oC for 20 h. After 
the hydrothermal treatment, the formed precipitate was washed and dried at 100oC. As 
a result, a highly disperse TiO2 powder was obtained, which was further exposed to 
doping modifications. The N-doped TiO2 has been prepared by adding the urea 
solution into sol-gel solution. In case of Zr and Fe doped TiO2 materials the doping 
procedure was carried out by chemical vapour deposition (CVD) using zirconyl 
chloride (ZrOCl2) and FeCl3 solutions. This procedure is explained below. The titania 
precursor was placed into a quartz tube reactor of 2 cm x 25 cm size. Prior to heating, 
the reaction system was purged with dry nitrogen. Then the TiO2 precursor was 
contacted with a nitrogen stream flowing through the vessel containing the ZrOCl2 or 
FeCl3 solution and heated to 350°C. In case of N - doping, the precursor (already 
treated with urea) was placed in the apparatus and treated with nitrogen stream. After 
completing deposition, the materials were heated up to 500°C. The resulting doped 
TiO2 photocatalysts were washed and calcined in air before photocatalytic testing. 
The experimental set up is shown in Figure 6. 
 
 
Figure 6. Scheme of Zr-doping of TiO2 by chemical vapour deposition (CVD) method. 
 
The obtained Zr-doped titania photocatalyst contained ca. 5 mol % of zirconium. The 
XDR pattern (Fig. 7) confirms that the sol-gel derivates titania indicates the anatase 
crystal structure (after calcinations at 500°C) with increased crystallinity (narrow 
peaks). 
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Figure 7. XRD pattern of sol-gel titania after hydrothermal treatment at 500°C.  
 
The prepared 5 % Zr-doped titania adopts an anatase structure. Low concentration of 
dopant does not change significant the XRD patterns and no additional crystalline 
phases appear in the sample. Doping with N and Fe elements did not markedly 
influence the crystal structure and texture, which may be due to low concentration 
used, what was also observed by Lukáč et al.[20]  
The TEM image shows that the Zr-doped TiO2 material consists of inter - grown 
nanoparticles. The particles are compact and with regular shapes, 10 - 15 nm small 
and agglomerated (Fig. 8). The agglomerates contain mesopores between the Zr-TiO2 
crystals.  
 
 
Figure 8. TEM image of Zr-TiO2 photocatalyst. 
 
The BET surface area of Zr-TiO2 amounts to 100 m
2/g. The nitrogen adsorption-
desorption isotherms of Zr-TiO2 shows an additional adsorption step with a slight 
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hysteresis at relative nitrogen pressure (p/p0) of 0.7 - 0.9 due to the presence of 
mesopores (Fig. 9). The mesopore volume of Zr-TiO2 amounts to 0.25 cm
3/g. The 
BJH desorption analysis shows uni-modal mesopores with relative narrow size 
distribution having the pore size maximum at ca. 8-9 nm.  
 
 
Figure 9. Nitrogen adsorption-desorption isotherms of Zr-TiO2 photocatalyst.  
 
Titania nanotubes (TNs) 
Titania nanotubes are low crystalline titania materials with tubular (needle-like) shape 
containing one-dimensional round pores of uniform size ranging usually from ca. 5 -
30 nm. TN particles are obtaining by hydrothermal treatment of titania. These 
structures are composed of TiO6 octahedron sheets connected by edges and corners.  
The TiO6 octahedron in titania nanotubes and its comparison with TiO6 octahedron of 
rutile is presented in Figure 10. 
 
Figure 10. Comparison of titania structures: (a) TiO6 octahedron in rutile TiO2 and (b) TiO6 octahedron 
in titania nanotubes (TNs).[21] 
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However, in the literature there is luck of comprehensive understanding of the 
building blocks of titania nanotubes, the proposed structure of the anatase unit cell in 
titania nanotubes is shown in Figure 11. The unit cell of anatase is cleaved in the 
[001] direction with a spacing of 8.7 Å and give a possible delaminated form of 
anatase. Titania nanotubes are composed of delaminated anatase, where these layers 
are located in [001] direction.  
 
Figure 11. Comparison of the unit cells of (left) anatase and (right) sheets of titania nanotubes made of 
delaminated anatase.[22] 
 
The crystalline raw material is first converted to an amorphous product through alkali 
treatment, and subsequently, titania nanotubes are formed after treatment with 
distilled water and HCl aqueous solution.  
 
The formation and transformation of nanotubes prepared by the NaOH treatment and 
post-treatment washing is summarized in Figure 12. 
 
 
Figure 12. Overall scheme for the formation and transformation of nanotubes induced by the NaOH 
treatment and the post-treatment washing.[23] 
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During NaOH treatment, some of the Ti-O-Ti bonds are broken, forming an 
intermediate containing Ti-O-Na and Ti-OH. These intermediates would proceed with 
rearrangement to form sheets of edge sharing TiO6 octahedra with Na
+ and OH- 
intercalated between the sheets. The formed structure is Na2Ti2O5∙H2O (i.e. 
Na2Ti2O4(OH)2). The sodium titanate exhibits layers of the TiO6 octahedra edge 
shown in a zigzag configuration (Figure 12 b) which is unit layer of the anatase TiO2 
projected along [101] (Figure 12 a). If the two longer Ti-O bonds in the TiO6 
octahedra are broken, the anatase TiO2 would transform into the layered titanate. The 
formed Na2Ti2O5∙H2O can exchange ions Na
+ with H+ in the post-treatment acid 
washing. The exchange would result in a variation of the surface charge, leading to a 
peeling-off of the individual layers of the titanate and subsequent scrolling of the 
layers into nanotubes (Figure 12 c). The x value of the nanotube structure, Na2-
xHxTi2O5∙H2O, would increase with the acidity of the post-treatment. During this 
transformation, the titanate framework would shrink by reducing the interlayer 
distance and can then transform into titanate nanotubes (Figure 12 d) via a soft-
chemical route, i.e. by backwashing with NaOH. Further increase the pH value in the 
backwashing to above pH of 8, would form crystalline titania plates.  
 
In our laboratory the synthesis of titania nanotubes were carried out by hydrothermal 
treatment as follow: 
A 1 g of titania (Degussa P25) was introduced into a Teflon autoclave (80 mL) 
containing 60 mL 10 M NaOH.  
The suspension was stirred for 1 h and then ultrasonically treated for 1 h in order to 
receive a sufficient dispersion of titania particles in the reaction mixture. Then, the 
autoclave was heated up constantly to 150°C for 24. After hydrothermal treatment the 
NaOH solution was decanted and the precipitate was dispersed in 0.01M HCl and 
washed until neutral. Finally, the precipitate was dried in air for 48 h (as-synthezied 
TN) and calcined at 700°C for 1h (sample denoted as TN_700). 
Figure 13 shows the XRD patterns of titania nanotubes. As it was former observed, 
the starting material titania is composed of the anatase co - existing with rutile phases 
(compare Fig. 3). After chemical treatment the TiO2 nanoparticles were transformed 
into tubular morphology (titania nanotubes). The XRD pattern shows the typical 
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reflections observed with as - synthesized TiO2 nanotubes (Fig. 13 left).
[24] The peaks 
are broadened and of low intensity indicating the low crystallinity of the material. 
However three reflections located at 2 Theta at 24, 28 and 48° have been assigned to 
titanates such as A2Ti2O5·H2O (A indicates Na
+ or H+ ions).[25-27] These results are in 
line with other study.[28]  
 
Figure 13. XRD patterns of titania nanotubes (left) as-synthesized (TN) and (right) calcined at 700°C 
(TN_700); fraction of Ti-titanates, A - anatase, R - rutile phases and Na - sodium hexatitanate. 
 
The further thermal treatment (calcination) of titania nanotubes changes the structure 
of the material, indicating limited thermal stability. After calcination at 700°C, the 
crystallinity of TiO2 nanotubes increases, but still is low what is confirmed by low 
intensities of X - ray reflections. This observation is in good agreement with other 
studies.[29] The tubular elongated structures are changed to different shaped particles 
as seen with TEM (Fig. 14). Besides of some titanates, indicated by X-ray reflections 
at 2 Theta at 24 and 48°,[30] also sodium hexatitanate is found in the material giving 
rise to a peak of high intensity at 2 Theta at 30°.[31] Also some anatase (A) and rutile 
(R) is present in the calcined TN[32] (Fig. 13 right). The crystallinity of the material is 
still low (amorphous - like). 
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a)  b)  
Figure 14. TEM images of titania nanotubes (a) as-synthesized (TN) and (b) calcined at 700°C 
(TN_700). 
 
The TEM images show titania nanotubes obtained by a hydrothermal treatment (Fig. 
14). The as - synthesized titania nanotubes are uniform along their length (inner and 
outer diameters) and have diameters of ca. 10 nm and lengths of hundreds nanometers 
(Fig. 14 a). Further calcination at 700°C shows the changing in the titania structure by 
forming spherical particles of ca. 20 to 50 nm size (Fig. 14 b). 
 
The nitrogen adsorption - desorption isotherms of titania nanotubes are shown in 
Figure 15. 
 
Figure 15. Nitrogen adsorption-desorption isotherms of titania nanotubes.  
 
The hollow tubular structures of as - synthesised titania nanotubes have a specific 
surface area of 105 m2/g. The adsorption isotherm shows an additional adsorption step 
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with a slight hysteresis at relative nitrogen pressure (p/p0) of 0.4 - 0.8 (desorption 
branch). This indicates that the product is mesoporous (2 - 50 nm) in contrast to the 
starting material titania P25. The mesopore volume of as-synthesized TN amounts to 
0.216 cm3/g having the pore size maximum of ca. 4.3 nm. Whereas the BET surface 
area of titania nanotubes calcined at 700°C is markedly decreased to 14 m2/g. At the 
same time the specific pore volume is decreased from 0.216 and 0.06 cm3/g. This 
finding is confirmed by other studies; where calcination markedly influenced the 
specific surface areas of TNs decreasing the specific surface area from 225 to 18 m2/g 
after calcination at 700°C.[33] The high surface area of the as-synthesized TN and 
nanotubular structure has been found to be maintained up to ca. 400°C. At 450°C a 
suddenly decrease to 100 m2/g occurs.[34]  
In conclusion, the calcination of nanotubes and formation of titania particles at 700°C 
is accompanied by markedly loss of porosity and decrease of specific surface area, 
suggesting the collapse the tube structure. 
 
Titania/MIL-101 composite and MIL-125 photocatalyst 
Chromium-titania composites Ti/MIL-101 based on metal organic framework possess 
the chromium sites in the MOF structure. TiO2 was inserted by depositions of 
hydrolysed titania tetrachloride. The structure of as-synthesized MIL-101 is given in 
Figure 16. 
 
 
Figure 16. Representative MIL-101 structures consisted of tetrahedron building units (ST) shows the 
trimeric building block chelated by three carboxylic functions (left). The ST was constructed with 
(middle) terephthalic acid, which lies (right) on the edges of the ST. Chromium octahedra, oxygen, 
fluorine and carbon atoms are in green, red, and blue, respectively.[35] 
 
In detail, the MIL-101 precursor, used further for the preparation of Ti/MIL-101 is 
composed of inorganic trimeric octahedral chromium metal building blocks and 
alternative arranged organic 1,4-benzene dicarboxylate (BDC) linker as primary units. 
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They form so-called supertetrahedral secondary units (ST) building up the ordered 
and highly porous crystalline framework of the chemical composition 
[(Cr3X(H2O)2O(O2C–C6H4–CO2)]3·25H2O, with X = F, OH. The pore system of MIL 
- 101 consists of two different sized extra-large cages. The smaller one is accessible 
via pentagonal windows of ca. 12 Å size. The larger cage has both pentagonal (12 Å) 
and hexagonal windows of ca. 14.5 × 16 Å size. The two large cages are delimited by 
20 and 28 ST units, respectively. The ST units are microporous with trigonal pore 
openings of ca. 8.6 Å and can be considered as “side pockets” of the walls of the large 
cavities.[35] MIL-101 material was typically synthesized in the following way: 
A solution containing chromium(III) nitrate 16 g Cr(NO3)3∙9H2O + 192 ml H2O was 
added 8 ml hydrofluoric acid (5M) and 6,56 g 1,4-benzene dicarboxylic acid 
(H2BDC) under stirring in 2 hours. The mixture was put into the autoclave and heated 
at 220°C for 9 h. To eliminate most of the carboxylic acid, the mixture was filtered 
first using a large pore (Attman n°2) paper filter (n°2); the water and the fresh MIL-
101 powder passes through the filter while the free acid stays inside the glass filter. 
Then, the MIL-101 powder is separated from the solution using a small pores (n°5) 
paper filter. To remove H2BDC in MIL-101 pore, the obtained powder was treated in 
ethanol at 100°C in 22 hours, then filtered, washed and dried (Fig. 17 left). 
 
Preparation of Ti/MIL-101 was carried out as followed: 
100 ml solution of TBOT in i-PrOH (0.25 M) was added to 2 g of activated MIL-101 
under vigorous stirring at room temperature during 20 hours. The resulting solid, 
MIL-101 was washed by i-PrOH to remove excess of TBOT before treated in 
hydrothermal condition at 220°C in 4 hours. Finally, the powder was filtered, washed 
and dried at 110°C in 2 hours (Fig. 17 right). The titanium content was determined by 
EDX. Obtained composite samples are denoted Ti/MIL-101 containing 6.6 and 10.94 
Ti (wt.%). The 
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Figure 17. Synthesis scheme of the precursor MIL-101 (left) and Ti/MIL-101 composite (right). 
 
XRD pattern of Ti/MIL-101 is given in Figure 18. The obtained diffraction pattern is 
in agreement with the simulated one confirming the formation of the MIL-101 
structure.[35,36] The diffractogram shows resolved and narrow reflections indicating a 
well-crystallized MIL-101 material with the characteristic peaks at the 2 Theta of 1,9o, 
2,8o, 4,9o and 9o.[37] It was proved that the MIL-101 structure was not broken by 
loading of TiO2. The modification of MIL-101 with titania does not change markedly 
the crystallinity of MOF material. In addition, X-ray diffraction of TiO2 loaded MIL-
101 materials shows a broadened peak at 2 Theta of 25o belonging to anatase 
evidencing that the obtained materials is an anatase/MIL-101composite. 
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Figure 18. XRD pattern of Ti/MIL-101 composite. 
 
TEM and SEM images show highly agglomerated particles of Ti/MIL-101. The 
particles of titania is < 10 nm. They form clumps of particles (Fig. 19 and 20). 
 
  
Figure 19. TEM images of Ti/MIL-101 at different magnifications; Ti content of 10.94 Ti (wt%). 
 
  
Figure 20. SEM images of Ti/MIL-101 at different magnifications. 
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The nitrogen adsorption-desorption isotherms of the sample is shown in Figure 21. 
The adsorption isotherm shows three distinct adsorption steps. At a very low relative 
pressure up to p/p0 of 0.01, the uptake curve shows a very steep increase. It is 
assigned to the filling of micropores. Between the relative pressure of p/p0 of 0.01-0.2, 
the slope of the adsorption isotherm decreases. This second step is related to the 
filling of small mesopores followed by a third step near p/p0 of 0.25 of final pore 
filling. Further nitrogen uptake at the high relative pressure above p/p0 of 0.8 is due to 
textural porosity. The similar, characteristic adsorption isotherms are former reported 
in studies.[38] The well resolved adsorption steps of the isotherm and the high uptake 
confirms the formation of the well crystallized MIL-101. The BET area of the 
prepared MIL-101 is of very high value and amounts 4703 m2/g. 
 
 
Figure 21. N2 adsorption and desorption isotherm of the MIL-101 measured at -196
oC. 
 
The photocatalytic activity of Ti/MIL-101 has been compared with the metal organic 
framework MIL-125. Both materials possess the terephthalic acid linker. MIL-125 
(Ti) or Ti8O8(OH)4[O2C-C6H4-CO2]6 material possess the titania (Ti) isolated sites in 
the MOF framework (titania octahedron rings as metalsites) (Fig. 22). The preparation 
procedure is presented in the literature.[39] MIL-125, the first example of a highly 
porous and crystalline titanium (IV) dicarboxylate MIL material shows a high thermal 
stability and photochemical properties. Its structure is built up from a pseudo cubic 
arrangement of octameric wheels, built up from edge- or corner-sharing titanium 
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octahedra, and terephthalate dianions leading to a three-dimensional periodic array of 
two types of hybrid cages with accessible pore diameters of 6.13 Å and 12.55 Å. 
 
 
Figure 22. (a) Perspective view of a centered cubic (cc) arrangement; the 12-fold coordination is 
evidenced by yellow lines. Purple and orange dots indicate the positions of the centers of the 
tetrahedral and octahedral vacancies. (b) View of the perforated cyclic octamer with edge- and corner 
sharing Ti octahedra; it corresponds to the atom with an orange circle of the classical cc packing 
through the SBU augmentation. (c) Perspective view of MIL 125 with the central octamer surrounded 
by 12 others; the pink and blue stars indicate the centers of the tetrahedral and octahedral vacancies in 
MIL 125. (d) Ball and stick representation of the octahedral vacancy, filled by water molecules (in 
green); the large yellow sphere represents the effective accessible volume of the cage. (e) The 
tetrahedral vacancy; in (d) and (e) the color code is as follows: carbon, gray; oxygen, red; water, green; 
titanium, yellow.[39] 
 
TEM images shows that the MIL-125 material consists of agglomerated small 
nanocrystals (Fig. 23). The particles have a size of ca. 100 nm. A high textural 
porosity of the MIL-125 is observed with combined micro - meso - macro pore 
system (isotherms not shown). Nitrogen sorption measurements gave a BET surface 
area of 1360 m²/g. Further characterization is given in literature.[39] 
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Figure 23. TEM images of MIL-125 photocatalyst at different magnifications. 
 
Zinc oxide nanoparticles (ZnO) 
Zinc oxide crystallizes in the hexagonal wurtzite structure type. The crystal structure 
of zinc oxide is given in Figure 24. ZnO exhibits similar oxidation properties to TiO2, 
including the formation of •OH radicals and the direct oxidation by photogenerated 
holes.[40] ZnO is reported to be as reactive as TiO2 under concentrated sunlight, as the 
band gap energy of ZnO is almost equal to that of TiO2 (i.e., 3.1 - 3.2 eV).
[41] Also a 
larger band gap of 3.37 eV[42] has been reported for pure ZnO. The density of ZnO is 
5.6 g/cm3.[43] 
 
 
Figure 24. The structure of ZnO (source: www.en.wikipedia.org). 
 
Depending on the solvent, precipitation either in water (ZnOw) or in ethanol (ZnOe), 
two types of ZnO of different size were prepared. The ZnO nanoparticles have been 
synthesized by a soft precipitation performed in the following way. Ca. 30 mmol of 
zinc nitrate hexahydrate were dissolved in 60 mL of H2O at room temperature under 
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continuous magnetic stirring. In a separate beaker, 60 mmol of CHA were dissolved 
in 20 mL of water at room temperature. The CHA solution was poured into the zinc 
solution. A white precipitate was formed upon magnetic stirring. An extra amount of 
80 mL of water was added to the reaction mixture, which was left stirring for four 
days. The precipitate was filtered off through an F-size fritted filter, and then washed 
with 100 mL of H2O. The precipitate was dried under vacuum for one day. Thereafter, 
it was suspended in 300 mL of water and magnetically stirred for one day, then 
filtered off and dried. Alternatively the synthesis was carried out in the same way in 
EtOH to obtain smaller ZnO nanoparticles (ZnOe). All samples were calcined at 
500°C for photocatalytic use. 
Figure 25 shows the XRD patterns of two nanosized zinc oxides prepared from 
aqueous and ethanolic solutions. The reflections of as-prepared materials are broader 
indicating some structural disorder or formation of small crystallites in the as-
prepared samples, especially in case of precipitation from ethanol. Calcination of the 
samples increased the crystallinity of materials. Both materials show similar 
crystallite sizes of average size of ca. 29 nm. 
 
 
Figure 25. XRD patterns of nanosized zinc oxides prepared by precipitation from aqueous (ZnOw) and 
ethanolic (ZnOe) solutions. From top to bottom: a) ZnOw calcined at 500°C, b)  ZnOe calcined at 500°C, 
c) as-prepared ZnOw and d) as-prepared ZnOe.  
 
The TEM images confirm the crystallization of zinc oxide nanoparticles (Fig. 26). 
The particle obtained with H2O are larger (ca. 100 nm) than those obtained from 
EtOH solution (ca. 15 - 30 nm). ZnOe nanoparticles are uniform shaped and 
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agglomerated. The replacement of ethanol by water leads to rapid precipitation of 
ZnO and formation of the large non-uniform nanoparticles.  
 
a)   
b)   
Figure 26. TEM images of ZnO nanoparticles precipitated from a) ethanol (ZnOe) and b) water 
(ZnOw). 
 
The nitrogen adsorption isotherms are shown in Figure 27. They show a low nitrogen 
uptake at low pressure. In case of ZnOe an additional increase of the isotherm at p/p0 
> 0.8 indicates the presence of nanoporosity. The specific surface areas are ca. 8 m2/g 
for the zinc oxide derived from aqueous solution (ZnOw) and ca. 40 m
2/g for the 
material obtained in ethanol (ZnOe), reflecting the different nanoparticle sizes 
(compare Fig. 26). 
 
 125 
 
 
Figure 27. Nitrogen adsorption-desorption isotherms of zinc oxide photocatalysts. 
 
A 1.2. Photocatalytic testing and experimental procedure 
 
Materials 
Two model pharmaceuticals have been chosen as new emerging water pollutants i.e. 
an antibiotic tetracycline and a non-steroidal anti-inflammatory drug ibuprofen. 
Tetracycline chloride (TC) 95% (C22H24N2O8·HCl) was purchased from Sigma (Fig. 
28 a). Ibuprofen sodium salt (IBP) 98 % (C13H17O2Na) was supplied by Sigma-
Aldrich (Fig. 28 b).  
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Figure 28. Structures of a) tetracycline and b) ibuprofen. 
 
Ibuprofen is an organic compound belonging to the class of propionic acid 
derivatives. Ibuprofen as a non - steroidal anti - inflammatory drugs (NSAID's) is 
used to treat mild pain and lower fevers. It is a stable white crystalline powder slightly 
soluble in water. Ibuprofen is a weak acid (pKa = 4.4).[44]  
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Tetracycline consists of four six - membered rings usually denoted as A, B, C and 
D.[45] The stereochemistry is very complex since carbon atoms 4, 4 a, 5, 5 a, 6 and 12 
a can, in principle, be asymmetrically substituted. Depending on the pH of the 
solution, tetracycline is presented in different protonated states (Fig. 29). In aqueous 
solution, the first deprotonation of the fully protonated species, termed ab+c occurs at 
pKa = 3.1 - 3.5. This step leads immediately to the zwitterionic form of the neutral 
compound a-b+c, which represents a non-ionised form (abc). In case of large 
difference of pKa2 = 7.2 - 8.5 and pKa3 = 9 - 10.9, there is no doubt about the complete 
deprotonation. 
 
 
Figure 29. Acid-base equilibria and ionization states of tetracycline (a) pKa=3.3, (b) pKa2=7.5 (c) 
pKa3=9.4.
[46] 
 
The relative amount of occurring species of TC is shown in Figure 30. Between ca. 
pH 4.2 and pH 7.2, the zwitterionic species a-b+c are the dominant ones. Around pH 9 
about 80 % of the molecules are presented as anionic species a-b+c-.[47] 
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Figure 30. The influence of the pH value on the distribution of tetracycline species in aqueous 
solution.[48] 
 
The zwitterionic character of the TC molecule is influenced by change of pH value. 
At acidic, neutral and alkaline conditions different deprotonated states of TC occur. In 
acidic solution, after adding the strong acid, fully protonated (cationic) states is 
observed (b+). By adding the strong base, the TC states are changing. The hydroxyl 
group is deprotonated forming the (a-) anionic state of TC. With increasing pH value, 
next protons are removed from the OH groups. Finally, the complete deprotonation of 
TC molecule is achieved at pH of 9 - 10.9, forming the anionic TC species (a- b c-). 
 
Photocatalytic performances 
The photocatalytic abatement of two model pharmaceuticals: tetracycline and 
ibuprofen was carried out under reliable conditions. A 1 L glass baker (a batch 
reactor) was placed into a closed aluminum box equipped with four UV-Vis solarium 
lamps and irradiated from the top with a total power of 60 W (4 lamps x 15 W, 
Phillips). The irradiation intensity of the experimental setup was 3.2 mW/cm2. These 
lamps mainly simulate the UV part of sun light between 320 nm and 400 nm besides 
of additional emission lines in the visible light range. The irradiation intensity was 
similar to sun light radiation at the Baltic Sea, Rostock, on a clouded day and 
measured using an UV light meter. The distance between applied lamps and the 
surface of pollutant solution was 15 cm (Fig. 31). 
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Figure 31.  Scheme of the photocatalytic batch reactor.  
 
Appropriate amount of photocatalysts were added into pollutants solution. The 
solution was further mixed magnetically during the adsorption and photocatalytic 
experiments. The photocatalysts were separated from the aliquots by using a 0.45 μm 
PTFE filter and then taken for further quantitative analysis. Additionally, adsorption 
measurements were carried out in the same way; in the closed aluminum box, without 
any irradiation (experiments in the dark). The quantitative progress of the oxidative 
photocatalytic abatement of ibuprofen and tetracycline was estimated using the 
calibration data.  The concentration of high concentrated ibuprofen and tetracycline 
solutions (ppm range) was monitored by UV - Vis spectrometer (Varian, Cary 
WinUV). While for the determination of low concentrated tetracycline solutions (ppb 
range) a new measurement procedure has been developed based on voltammetry. 
 
Reaction intermediates 
The quantitative abatement of the pharmaceuticals was followed by the disappearance 
of the band corresponding to ibuprofen and tetracycline at 222 and 360 nm, 
respectively (Fig 32 and 33).  
The IBP absorbance intensity at 222 nm markedly decreases with treatment time. 
Additionally, a second absorbance at 262 nm appears during the course of the 
treatment, what is attributed to the formation of temporary products of ibuprofen in 
the solution (Fig. 32 arrow).  
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Figure 32. UV-Vis spectra of an aqueous ibuprofen solution after photocatalytic treatment over titania 
25 photocatalyst under UV-Vis irradiation: (1) starting IBP solution (10 ppm) and after (2) 5 min, (3) 
30 min, (4) 60 min, (5) 120 min, (6) 180 minutes of photocatalytic treatment. Concentration of 
ibuprofen determined based on the absorbance at 222 nm. Experimental conditions: IBP conc.: 10 ppm, 
cat conc.: 20 mg/L, cat-to-sub ratio of 2:1, pH=7. 
 
In case of tetracycline, the concentration was determined based on the absorption 
band at 360 nm. During the course of abatement no other bands appear which could 
be used to check the appearance of intermediates as is was with IBP (Fig. 32). 
 
 
Figure 33. UV-Vis spectra of an aqueous tetracycline solution after photocatalytic treatment over 
titania 25 photocatalyst under UV-Vis irradiation: (1) starting TC solution (10 ppm) and after (2) 5 
min, (3) 10 min, (4) 30 min, (5) 60 min, (6) 120 min, (7) 180 min, (8) 240 minutes of photocatalytic 
treatment. Concentration of ibuprofen determined based on the absorbance at 362 nm. Experimental 
conditions: TC conc.: 10 ppm, cat conc.: 10 mg/L, cat-to-sub ratio of 1:1, pH=7. 
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ESI-TOF-MS/HPLC 
The ibuprofen and tetracycline intermediates formed during photocatalytic treatment 
were qualitatively investigated and determined by ESI-TOF-MS measurements using 
an electrospray ionization mass spectrometer HPLC System 1200/ESI-TOF-MS 6210 
(Agilent). The ESI-TOF-MS uses a “soft” ionisation method to obtain positively or 
negatively charged molecule ions by adding or removal the protons from the 
molecule. The deprotonated molecular ion of the formula [M-H]- formed in the 
negative ionisation mode gives the signals, which are plotted as mass-to-charge (m/z) 
peaks vs. counts  (intensities). They allow for a qualitative determination of IBP and 
TC and its decomposition products in the aqueous solution.  
 
 
Figure 34. Negative ESI-TOF-MS of starting aqueous solution of ibuprofen 20 ppm. 
 
The negative ESI-TOF-MS spectrum shows the intensity vs. mass-to-charge (m/z) 
peaks of the starting ibuprofen solution (Fig. 34). Beside the molecular peak at m/z 
205 attributed to the ibuprofen anion, higher mass-to-charge peaks are observed at 
m/z 433, 661 and 889.  The mass signals at m/z 205 and m/z 433, 661 and 889 
indicates some impurities in the sample. The peaks arising at m/z 501 and 729 are 
belonging to formed molecular self - aggregates of ibuprofen sodium salt. 
 
Voltammetry 
The polarographic method voltammetry has been developed for the detection of 
tetracycline at very low concentration (ppb range).[49] For this purpose the 
measurement conditions of used modes have been optimized by lengths. The 
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optimization included, e.g. the type of the buffer, the pH value of the solution as well 
as the accumulation time, deposition potential and modes. This way the detection 
limit of tetracycline could be extended to 1 ppb and lower. The limit of detection of 
tetracycline was further extended down to 45 ppt based on square wave voltammetry 
(SWV) (Fig. 35). This novel procedure enables to determine TC contaminations down 
to the low ppt- ppb-level using the popular hanging mercury electrode (HMDE).  
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Figure 35. Calibration curves of tetracycline based on SWV representative peaks shown in inset. The 
limit of detection (LOD) was found at ca. 45 ng/L using the prediction bands of the calibration data set. 
 
The deeply development of this sensitive electroanalytical method allowed to 
determine the photocatalytic abatement of low tetracycline concentrations of 200, 500 
and 1000 ppb in aqueous solution. The changes of TC concentrations have been 
monitored by adsorptive stripping voltammetry (AdSV) using the Polarograph 797 
VA Metrohm AG, (Herisau, Switzerland).  
The electrochemical cell has been equipped with the hanging mercury drop electrode 
a working electrode and with a reference electrode in a supporting electrolyte e.g. 
boric acid solution. All solutions were prepared using ultrapure water (> 18 MΩ TOC 
< 2 ppb). The stock solution containing 100 ppm of tetracycline in water was prepared 
daily. The buffer solution: a 0.025 M boric acid aqueous solution was adjusted to pH 
7 and used as supporting electrolyte. For analysis 10 mL aliquots of the reaction 
solution containing tetracycline (taken after photocatalytic treatment) were pipetted 
into the electrochemical cell containing 10 mL of buffer and was deoxygenated by 
purging with nitrogen for 300 seconds. Each measurement was repeated three times 
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including intermediate purging for 30 sec. The stirring (2000 rpm) was kept constant 
during the deposition at the hanging mercury drop electrode, by using the fresh 
mercury drop. The deposition time was 200 sec. The voltammograms were recorded 
over the range of -0.60 V to -1.60 V, where the height of the reduction peak at -1.2 V, 
corresponding to TC peak, was taken to determine the calibration curve (Fig. 36). All 
data were obtained at room temperature. 
 
 
 
 
Figure 36. The calibration plot and adsorptive stripping voltammetric response (inset) of 0, 0.05, 0.1, 
0.2, 0.5, 1 and 2 ppm (from top to bottom) in 25 mM boric acid solution (pH 5.5) detection limit ca. 10 
ppb. 
 
Finally, this work deals with the preparation of new active photocatalytic materials 
and development of the analytical procedures for the detection of pharmaceuticals at 
low ppm-ppb scale. A couple of  photocatalytic materials which differ in the nature 
and structure have been prepared and characterized regarding crystallinity, 
morphology and texture, mainly by XRD, TEM and N2 adsorption measurements 
(Tab. 1). List of the prepared active photocatalytic materials is given below: 
 Commercial TiO2 - mixture of rutile and anatase.  
 Nitrogen (N), iron (Fe) and zirconium (Zr) doped titania. 
 Titania nanotubes (TNs) - titania composed of (TiO6) octahedron sheets. 
 Ti/MIL-101, titania/MOF composites incorporated with chromium and 
titanium. 
 MIL-125 structures. 
 Two different sized zinc oxide (ZnO) nanoparticles.  
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Table 1. Comarison of the morphological properties of used photocatalysts. 
Photocatalysts Structure type 
Specific surface 
area [m2/g] 
Bang gap [eV] 
Particle size 
[nm] 
Titania P25 
anatase/ 
rutile 
55 3.2 10-30 
Zr-TiO2 anatase 100 2.9 10-15 
as-synthesized TN TiO6 rings 220 
- 
10x100-200 
TN calcined 
transformed to 
antase 
105 20-50 
Ti/MIL-101 MOF 3488 - - 
MIL-125 MOF 1360 - - 
ZnOe wurtzite 8 3.17 100 
ZnOw wurtzite 40 3.16 15-30 
 
The electrochemical method like voltammetry has been chosen for the development of 
determination of the test molecule tetracycline at low concentration (ppb range). By 
standardization of the experimental parameters like: buffer, pH value of solution, the 
deposition time and potential, the detection limit was successfully decreased to low 1 
ppb range. The influence of tap water matrix on the presence of tetracycline has been 
also checked (water matrix similar to waste and surface waters) but so far, not applied 
in the photocatalytic course of abatement.  
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